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Abstract
Changes in synaptic structure in response to neuronal stimulation are believed to
underlie the processes of learning and long-term memory. However, the mechanisms for
these structural modifications are poorly understood. It is well-known that activitydependent synaptic modifications rely upon new protein synthesis, and rapid new protein
synthesis, at that. Therefore, it is widely believed that pools of messenger RNAs held in
a state of translational repression are transcribed in a neuronal cell body prior to
stimulation, and transported to the synapse, where they reside until stimulation occurs.
This study investigates the roles and interactions of translational repression
mechanisms to better understand how new synaptic growth is repressed or enhanced for
the purposes of long-term memory and learning. We found that miRNAs -315, -275, -11
and the miR-9 family are of particular interest for neuronal growth in Drosophila larvae
because they are extremely enriched in the larval CNS compared to the adult brain, and
are predicted to regulate mRNA targets that significantly contribute to neuronal
development. Furthermore, miR-315 and the miR-9 family bind and regulate a Futsch
(Drosophila homolog of mammalian MAP1B known to affect synaptic growth) reporter
in vitro, and the miR-9 family exhibits an increase in bouton numbers at muscles 6/7 of
the NMJ characteristic of an increase in Futsch levels when under-expressed. Curiously,
this same effect with seen with miR-9 family overexpression.
ii

While miRNAs are translational repressors and can clearly affect synaptic
structure on their own, components of the miRNA pathway further interact with other
translational repressors, including the Fragile-X Mental Retardation Protein (FMRP).
Although FMRP has been shown to interact with the miRNA pathway, and to regulate
Futsch, we could not discern down-regulation of a Futsch reporter from FMRP
overexpression in S2 cells, nor an interaction between FMRP and these miRNAs that
regulated a Futsch reporter in vitro. However, FMRP did interact with several P-body
components, including co-localization with HPat, Twin, and Me31B, as well as coimmunoprecipitation with HPat, Me31B and Dcp1. Genetic interactions between FMRP
and HPat and FMRP and Twin produced discernible phenotypes at the Drosophila NMJ,
suggesting this interaction is important for synaptic growth.
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Chapter One: Introduction
Chapter 1.1.: Translational Regulation: The Key to Long-Term Memory and
Learning
There is a philosophy in science that form fits function. Every structure exists for
a purpose, and is structured the way it is in order to fit that function for the overall benefit
of the organism. Though modern understanding of learning and long-term memory
mechanisms is still somewhat limited, evidence dating back decades suggests that the
structure of the synapse underlies learning and long-term memory processes (Davis,
1993; Heisenberg et al., 1985; Bailey and Chen, 1983). Synaptic stimulation triggers
protein synthesis-dependent synaptic growth and structural modifications (Schwartz et
al., 1971; Bliss and Lomo, 1973; Matsuzaki et al. 2004), and dysregulation of this
synaptic remodeling is correlated with neurological diseases (Steele et al., 2014; Kim et
al., 2013; Rage et al., 2013; Morris et al., 1990). Given the requirement for new protein
synthesis in this model, and the rapidity with which modifications begin to occur,
researchers turn to translational regulation as the key to learning and long-term memory
processes (Mikl et al., 2010).
Chapter 1.2: The Role of Ribonucleoproteins in Long-Term Memory and Learning
Ribonucleoprotein complexes (RNPs) are conglomerates of RNAs and proteins,
which can include components of the microRNA (miRNA) pathway, Processing Bodies
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(P-bodies), ribosomes and spliceosomes, and much more (Weil et al., 2012; Staley and
Woolford, 2009; Dostie et al., 2003). Given their diverse structures, RNPs can act as
chaperones to mediate mRNA folding, translational repression, or degradation (Lorsch,
2002; Fritzsche et al., 2013; Sheth and Parker, 2003). Special subsets of RNPs exist in
neurons and perform similar functions. Ergo, these complexes are the subject of great
speculation as potential mediators of learning and long-term memory disorders (Sleeman,
2013). For the purposes of this study, the focus on RNPs is restricted to their role as
potential mediators of mRNA translational repression and decay.
Chapter 1.3: The Role of microRNAs in Synaptic Growth
One of the more recent discoveries in RNPs is the involvement of small RNAs
known as microRNAs (miRNAs), and their pathway for translational repression: the
RNA-induced Silencing Complex (RISC; Keene, 2010). When combined, these form a
complex referred to as the miRISC (Nottrott et al., 2006). miRNAS are small endogenous
21-22 nucleotide sequences that are initially transcribed as a primary miRNA molecule
in the nucleus, which includes a hairpin loop and excess sequence on each end (Moss,
2002; see Figure 1). From there, the primary transcript is processed into a pre-miRNA
sequence by the enzyme Drosha, which cleaves off any sequence surrounding the hairpin
loop, and then the hairpin loop is exported from the nucleus by Exportin-5 to the
cytoplasm (Han et al., 2004; Yi et al., 2003). Dicer then cleaves off the hairpin loop and
processes the sequence to form a 21-22 nucleotide duplex (Bernstein et al., 2001). One
strand of the duplex associates with the RISC and base-pair matches to its target mRNA
sequence to induce translational silencing when the base-pair match is imperfect, or
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degradation in the presence of perfect base-pair complementarity (Hammond et al., 2000;
Hammond, 2005; Filipowicz et al., 2005). The RISC is composed of Dicer, Argonaute
proteins, RNA-binding proteins, and other components that mediate translational
repression (Chu and Rana, 2006).

Figure 1: The miRNA Process: From Transcription to Translational Regulation
The image above is from the Sigma-Aldrich miRNA Introduction webpage:
http://www.sigmaaldrich.com/life-science/functional-genomics-and-rnai/mirna/
learning-center/mirna-introduction.html. It illustrates the transcription and processing of
miRNAs from primary transcripts to mature sequences associated with the RISC to
induce translational repression or degradation of mRNA targets. Copyright 2014,
permission requested.
miRNA mis-expression can lead to dysregulation of target mRNAs. Ergo,
miRNAs are implicated in neuronal diseases such as Alzheimer’s Disease (Garza-Manero
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et al., 2013) and epilepsy (Gorter et al. 2014). miRNAs affect synaptic growth and
maturation by selectively targeting the mRNAs of proteins involved in synaptogenesis
(Siegel et al., 2011; Olde Loohuis et al., 2012; Nesler et al., 2013; Sun et al., 2013). To
understand their role in development, a key first step is to analyze the abundance of these
molecules at different stages of development in order to better understand how miRNA
expression contributes to development. Part of this study will investigate the differential
expression of miRNAs in the Drosophila larval CNS and adult CNS for the purposes of
guiding us to finding the most important miRNAs involved in synaptic development
between the larval and adult stages.
Chapter 1.4: The Role of the Fragile-X Mental Retardation Protein in Synaptic
Growth
RNPs are known to be comprised of components of the miRNA pathway, as well
as numerous RNA-binding proteins, including the Fragile-X Mental Retardation Protein
(FMRP), (Kanai et al., 2004; Höck et al., 2007). FMRP is so named because of its
relationship to the human disease known as Fragile-X Syndrome (FXS). FXS is
phenotypically characterized by facial dysmorphism, and macroorchidism, and is
strongly correlated with autism-spectral social and behavioral disorders (Bardoni et al.,
2000; Maurin et al., 2014; Reddy, 2005; Hatton et al., 2006; Hagerman et al., 2010). It is
the leading cause of genetically inherited mental retardation in males (McLennan et al.,
2011), caused by a genetically inherited expansion of the CGG trinucleotide repeat
domain preceding the gene Fmr1 (Verkerk et al., 1991). Expansion of this trinucleotide
to repeats above 200 leads to hypermethylation in the non-coding region upstream of
Fmr1, leading to transcriptional silencing of FMRP (Pieretti et al., 1991; Lightbody and
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Reiss, 2009). Absence of FMRP leads to increased numbers of dendritic spines in the
brain that are characteristically elongated and thin, reminiscent of immature dendritic
spines in both Fmr1 knock-out mice, as well as humans with FXS (Bakker et al., 1994;
Irwin et al., 1999; Irwin et al., 2000); this structural abnormality is thought to underlie the
cognitive impairments associated with the disease (Loesch et al., 2004). Therefore,
understanding the mechanisms by which FMRP normally inhibits this synaptic
overgrowth is key to revealing the pathology and potential therapeutic targets of FXS.
Chapter 1.5:

The Fragile-X Mental Retardation Protein is a Translational
Repressor: The Molecular Theory of Fragile-X Syndrome

FMRP contains RNA-binding domains, including the RGG motif as well as two
KH-homology domains (Kiledjian and Dreyfuss, 1992; Siomi et al., 1993a). It is an RNAbinding protein, and point-mutation of one of the KH-homology domains alone is
sufficient to induce Fragile-X Syndrome in humans, suggesting the RNA-binding
property of FMRP underlies its effects on cognition (Ashely et al., 1992; Siomi et al.,
1993b; de Boulle et al., 1993; Siomi et al., 1994). FMRP acts as a translational repressor
and its absence results in increased abundance of proteins related to synaptic growth
(Laggerbauer et al., 2001; Li et al., 2001). These proteins are most often synthesized
under the metabotropic Glutamate Receptor (mGluR) pathway, where activation of
mGluR1 and mGluR5 by synaptic stimulation induces local mRNA translation and thus,
synaptic growth associated with plasticity (Weiler and Greenough, 1993). This
association of FMRP with proteins linked to the mGluR pathway has led to the mGluR
Theory of FXS (See Figure 2; Dölen et al., 2007). Briefly, Figure 2 illustrates the mGluR
Theory of FXS derived from a previously-published figure (Penagarikano et al., 2007).
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Under normal conditions, local pools of mRNAs are present at the synapse. Stimulation
of mGluRs 1 or 5 in mammals leads to local translation of some of these mRNAs, while
FMRP represses the translation of others. In the absence of FMRP (as in the case of FXS),
stimulation leads to universal translation of the local pool of mRNAs, including those that
would normally be translationally repressed by FMRP, leading to overproduction of
proteins responsible for synaptic growth, thus inducing the synaptic overgrowth
phenotype of FXS. In Drosophila, only two mGluRs exist: DmGluRA and DmGluRB,
but inhibition of these receptors in flies lacking FMRP imitates the phenotypic effects
seen when mGluRs 1 and 5 in mammalian models lacking FMRP are blocked (McBride
et al., 2005).

Figure 2: The mGluR Theory of Fragile-X Syndrome
This image is derived from Penagarikano et al. (2007), and depicts the metabotrophic
Gluatamate Receptor Theory of Fragile-X Syndrome, whereby synaptic stimulation of
mGluRs 1 or 5 induces translation of local pools of messenger RNAs at the synapse, and
in the absence of FMRP, this leads to translation of targets that would normally be
repressed. Copyright 2007 by Copyright Clearance Center, used with permission.
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Part of the intention of this research is to use Drosophila as a model to reveal the
pathology mechanisms of FXS. The Drosophila neuromuscular junction (NMJ) is an
excellent model for studying neuronal function because it is accessible, easily
manipulable due to simple genetics, and the synapses are glutamatergic, and thus present
similar mechanisms to synapses in the mammalian central nervous systems (Collins and
DiAntonio, 2007). The Drosophila model of FXS, induced by deletion or mutation of the
gene Dfmr1, recapitulates the synaptic overgrowth reminiscent of the human disease.
Additionally, flies with FMRP mis-expression exhibit altered circadian behaviors that
mimic sleep problems in humans with FXS (Bakker and Oostra, 2003). Thus, Drosophila
is a widely-accepted model for investigating FXS.
Chapter 1.6: The Fragile-X Mental Retardation Protein Interacts with MicrotubuleAssociated Protein 1B and Its Drosophila Homolog Futsch
Among the interactions of FMRP, one of the best-known and well-studied is its
interaction with the microtubule-associated protein 1B (MAP1B). MAP1B and its
Drosophila homolog Futsch mRNAs immunoprecipitate with FMRP, and FMRP
overexpression is directly correlated to decreased expression of these respective proteins,
as well as a decrease in synaptic growth. Similarly, under-expression of FMRP upregulates MAP1B and Futsch expression, and correspondingly, synaptic growth (Lu et
al., 2004; Zhang et al., 2001). Thus, FMRP is presumed to bind to the MAP1B/Futsch
mRNA in order to prevent translation under normal conditions, and in the absence of
FMRP, MAP1B dysregulation causes the synaptic overgrowth characteristic of FXS.
Given the clear association of FMRP with MAP1B, and the role of MAP1B in
axonal growth (Mack et al., 2000; Lucas et al., 1998) one of the most important goals in
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revealing FXS pathology using Drosophila as a model is to identify where and how
FMRP binds to the Futsch mRNA. FMRP is known to bind to secondary and tertiary
RNA structures such as the loop-loop pseudoknot, also known as the “kissing complex”
(Darnell et al., 2005), and the G-quartet (Darnell et al., 2001). Although specific Gquartets are difficult to identify, there are several sites for potential G-quartets within the
Futsch mRNA that are candidate sites for FMRP binding and repression. This study will
investigate FMRP binding to a Futsch reporter.
Chapter 1.7:

The Fragile-X Mental Retardation Protein Associates with the
microRNA Pathway

In addition to FMRP’s role as an RNA-binding protein, part of its association with
RNPs involves association with components of the RNA Induced Silencing Complex
(RISC), and the miRNA pathway. FMRP co-immunoprecipitates with RISC component
Argonaute-2 (Ago2; Caudy et al., 2002), miRNA components Dicer (Ishizuka et al.,
2002) and Argonaute-1 (Ago1) in Drosophila, and the mammalian homologue of Ago1,
EIF2C2. Further, knockdown of Ago1 in Drosophila inhibits FMRP’s ability to induce
a rough-eye phenotype in flies when overexpressed in that tissue, implicating the miRNA
pathway as a necessary component for FMRP function (Jin et al., 2004). FMRP has been
shown to specifically immunoprecipitate with miRNAs (Edbauer et al., 2010). Thus, this
research will investigate the potential interaction between FMRP and miRNAs to induce
translational repression of mRNAs involved in synaptic growth.
We propose a model whereby FMRP binds to its target mRNAs using its RNAbinding domains, and then recruits the miRISC to that mRNA to induce translational
repression (see Figure 3).
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Figure 3: Proposed Model for FMRP Interaction with the miRNA Pathway
Above demonstrates the hypothetical model we propose for FMRP interaction with the
miRNA pathway for the purposes of FMRP-mediated translational repression of mRNAs
associated with synaptic growth. FMRP binds directly to the mRNA, and recruits the
miRISC, which then binds to the mRNA by miRNA base-pair matching to the target,
leading to translational repression.
Chapter 1.8: The Role of Processing Bodies in Synaptic Growth
Neuronal RNPs are composed not only of RNA-binding proteins and components
of the miRISC, but also components of other conglomerates such as P-bodies. P-bodies
include protein components such as Dcp1, Dcp2, Xrn1 (Coller and Parker, 2004),
Staufen, CCR4, Me31B, Trailerhitch, and HPat (Eulalio et al., 2007). Homologues for
many of these components can be found together in yeast, Drosophila, and mammalian
cells (Hillebrand et al., 2007). P-bodies contain mRNAs and can serve several purposes
for these mRNAs: transport (Krichevsky et al., 2001), degradation (Sheth and Parker,
2003), or translational repression. P-bodies interact physically with FMRP (Barbee et al.,
2006; Oh et al., 2013), as well as the miRISC (Chan and Slack, 2006). Given the role of
both FMRP and miRNAs as translational repressors, their interaction with P-bodies
suggests that these components may act in concert to regulate translation of target
mRNAs. This research will investigate the potential interactions between FMRP and P-
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body components, specifically Me31B, Twin (Drosophila homolog of CCR4), HPat, and
Dcp1.
Each component of P-bodies plays a different role in regards to mRNA targets.
Me31B is the Drosophila homolog of mammalian Rck, a DEAD Box helicase that acts
as an enhancer of mRNA decapping (de Valoir, 1991). Me31B co-localizes with FMRP
in embryos (Monzo et al., 2006) and co-immunoprecipitates with FMRP and other Pbody components in Drosophila head extract. When Me31B expression is diminished, it
ameliorates the rough-eye phenotype induced by FMRP overexpression in that tissue,
suggesting Me31B may mediate the function of FMRP (Barbee et al., 2006). In contrast,
CCR4 (Twin in Drosophila) is a primary and essential component of the deadenylation
complex in Saccharomyces cerevisiae (Behm-Ansmant, 2006; Daugeron et al., 2001;
Tucker et al., 2001), Drosophila, (Temme et al., 2004), and humans (Yamashita et al.,
2005). It associates in a complex with NOT1 and CAF1 for the purposes of deadenylating
mRNAs prior to degradation (Temme et al., 2010). Genetic knockdown of Twin by itself
produces a synaptic overgrowth phenotype at the Drosophila NMJ, which is exacerbated
by simultaneous knockdown of HPat (Pradhan et al., 2012). HPat is involved in the 5’ to
3’ mRNA decay pathway and is an activator of decapping. Its role and its association to
P-bodies are highly conserved in yeast, flies, and humans (Marnef and Standart, 2010).
HPat acts as a negative regulator of synaptic terminal growth at the Drosophila NMJ
(Pradhan et al., 2012). Finally, Dcp1 is the enzyme responsible for mRNA decapping and
acts in concert with its co-enzyme Dcp2. Dcp1 is essential for miRNA-mediated gene

9

silencing (Rehwinkel et al., 2005). Ultimately, all of these P-body components work in
concert to transport, degrade or repress mRNA targets.
Chapter 1.9: Goals For This Study: Identifying Roles for RNP Components in
Synaptic Growth
Altogether, the goal of this study is to investigate the interactions and overall roles
of components of neuronal RNPs for the purposes of affecting synaptic growth at the
Drosophila NMJ. The abundance of miRNAs at the Drosophila CNS at different
developmental stages suggests it will be important in the future to analyze roles of miRs
-315, -275, and -11, as well as the miR-9 family in synaptic development. Testing and
identification of real targets of these miRNAs from lists of predicted targets with known
roles in synaptic growth is key to furthering our understanding of how these small
molecules contribute to synaptic development.
FMRP is known to interact with components of the miRNA pathway and Pbodies, as well as the Futsch mRNA. This investigation elucidates the nature of some of
those interactions involved in mediating FMRP’s function as a repressor of synaptic
overgrowth by demonstrating that some of the most larvally-enriched miRNAs (miR-315
and the miR-9 family) repress the reporter of a published and presumed FMRP target,
Futsch. Although FMRP has been shown to regulate Futsch expression in vivo, our results
indicate that FMRP does not bind to a Futsch reporter to repress translation in vitro, nor
does FMRP interact in a physical complex with the miRNAs that do repress a Futsch
reporter in vitro.
The roles and interactions of P-body components is also elucidated. FMRP
interacts physically and genetically with components of P-bodies that, in some cases,
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leads to a change in the number of boutons at the NMJ. P-body components Me31B,
Twin, and HPat co-localize with FMRP in cultured neurons, and P-body components
Me31B, HPat, and Dcp1 co-immunoprecipitate with FMRP in cultured cells. Some of
these P-body components clearly play their own role in regulating synaptic growth, but
also enhance the effects of loss of FMRP at the NMJ. Loss of FMRP and either Twin or
HPat leads to a significant increase in the number of boutons at the NMJ, suggesting an
interaction between FMRP and these P-body components that affects synaptic growth.
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Chapter Two: Materials and Methods
Chapter 2.1: Differential Expression of miRNAs
RNA Isolation
For the RNA isolation from each of adult and larval brains, more than 100 total
brains were dissected out by 3 separate individuals, cleared of any structures other than
the optic lobes and ventral ganglia, and inserted into 333 µl of Trizol Reagent (Ambion).
Each of the 3 tubes generated by these individuals were then homogenized using a Kontes
Pellet Pestle Motor, then allowed to sit in Trizol for 5 minutes incubating to complete
lysis, and pooled. 200 µl of chloroform was added to the tube and mixed by hand-shaking
for 15 seconds. The tube was then incubated for 2.5 minutes at room temperature and
centrifuged for 15 minutes at 12,000 x g and 4˚C. The aqueous (top) layer was removed
and placed into a new RNase-free 1.5 mL conical tube, and 0.5 µl of 20 µg/µl glycogen
was added and mixed. 500 µl 100% isopropanol was then added and mixed, and the
samples were incubated at room temperature for 10 minutes, then centrifuged at 12,000xg
at 4˚C for 10 minutes. The isopropanol was gently removed using a micropipettor and
discarded. 1 mL of RNase-free 75% ethanol was added to the RNA pellet; this was mixed
by briefly vortexing, then placed at -20˚C.
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RNA Sample Quantity and Quality Analysis
RNA samples were centrifuged and ethanol was removed from the pellets. The
pellets were then dried and resuspended in 50 µl RNase-free water. Small aliquots were
saved for analysis and the remainder was flash-frozen on liquid nitrogen and stored at
-80˚C. RNA samples were then analyzed using a NanoDrop-1000 version 3.5.2
spectrophotometer and then using the Experion Standard Sensitivity RNA Analysis Kit
(BioRad). The primary samples were then submitted to the Genomics and Microarray
Core at the University of Colorado Denver for Next-Generation Sequencing.
RNA-Sequencing Analysis
Raw RNA-Sequencing reads were manipulated and analyzed using the Galaxy
program at UseGalaxy.org (Giardine et al., 2005; Blankenberg et al., 2010; Goecks et al.,
2010). Files were converted to FastQSanger format using the NGS: QC and Manipulation
FastQ Groomer tool. Reads were then trimmed of the adapter sequence
TGGAATTCTCGGGTGCCAAGG using the NGS: QC and Manipulation Clip tool, and
filtered for quality with a minimum quality score of 20, a maximum quality score of zero,
a minimum size of 18 base-pairs, and a maximum size of 27 base-pairs for non-pairedend reads allowing for zero base-pairs outside of the quality range.
Trimmed sequences filtered for quality were next uploaded to the MPI-HLR:
miRNA Identification miRNA pipeline (MIRPIPE; Kuene et al., 2014) using the FTP
server FileZilla. MIRPIPE combined clustered reads (isomiRs), mapped them to the
miRBase database (Kozomara and Griffiths-Jones, 2014; Kozmara and Griffiths-Jones,
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2011; Griffiths-Jones et al., 2008; Griffiths-Jones et al., 2006; Griffiths-Jones, 2004), and
quantified the number of reads.
To ensure that miRNAs were not overrepresented merely from obtaining more
reads in a particular tissue, each quantity was normalized by dividing the number of reads
of each miRNA by the total number of reads per tissue, then multiplying by 106 to
translate each quantity to reads per million. The reads per million in adult tissue were
then subtracted from the reads per million in larval tissue to find absolute enrichment for
each miRNA in larval CNS compared to adult brain. The top 15 most abundantly enriched
miRNAs in the larval CNS were then further processed by dividing the reads per million
in larval CNS by the reads per million in adult brain to show fold-enrichment.
For the purposes of target analysis, miRNA families were grouped together with
their number of reads, because these miRNAs have the same seed region binding
sequence and are therefore predicted to target the same mRNAs (Lucas and Raikhel,
2013). Lists of potential targets for the top 10 most enriched miRNAs/ miRNA families
were then compiled using the program TargetScanFly version 6.2 (Lewis et al., 2005;
Ruby et al., 2007; Bartel et al., 2007; Kheradpour et al., 2007). Target lists were then
processed using the cluster annotation function from the Database for Annotation,
Visualization, and Integrated Discovery (DAVID; Huang et al., 2009a; Huang et al.,
2009b) to analyze potential functional roles for these highly-enriched miRNAs. Those
miRNAs whose targets showed the greatest enrichment in functional annotation clusters
attributed to neuronal growth were analyzed further. The lists of compiled predicted
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targets for these miRNAs were compared for overlap in Microsoft Excel, then these lists
of overlapping targets were processed with the DAVID Bioinformatics program.
Chapter 2.2: Interaction Between FMRP and miRNAs to Target Futsch
In Silico Analysis
Leslie Rozeboom initially performed analysis using miRNA target prediction
algorithm, TargetScanFly at http://www.targetscan.org/fly_12/ (Release 5.1 Friedman, et
al. 2009). She input “Futsch” as the FlyBase symbol or ID and found that the miR-9
family and miRs -315, -963, and -976 were predicted to bind to the Futsch 3’UTR. Of
these, only miRs -9A, -9B, -9C, and -315 were found by microarray analysis and qRTPCR to be expressed in the larval CNS (Rozeboom, 2011).
S2 Cell Maintenance and Care
SL2 cells obtained from the Drosophila RNAi Screening Center were thawed
from a new vial and passaged every 3-7 days as per the instructions found at
http://www.flyrnai.org/DRSC-PRC.html. Briefly, a 1 mL vial of frozen cells was thawed
rapidly using room-temperature media and transferred to 4 mL fresh Complete
Schneider’s Media in a 25 cm2 culture flask (CellTreat). Cells were allowed to adhere for
2 hours prior to gently removing the media and adding back 5 mL fresh media. Cells were
then allowed to grow for 1-2 weeks to reach 100% confluence. After that point, cells were
allowed to grow to 70%-100% confluence before passaging 3 mL mature cells into 12
mL fresh Complete Schneider’s Media treated with 0.2% Fungizone (Gibco) in a 75 cm2
culture flask (CellTreat) every 3-7 days as needed. Cells were loosened from the adherent
surface by banging the flask against the lab bench prior to each passage.
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4 days prior to an experiment, cells were passaged. The SL2 cell population was
split in a 250 mL suspension flask (CellTreat) 24 hours prior to seeding using Complete
Schneider’s Media. The day of transfection, cell density was calculated using a Phase
Counting Chamber

(Hausser Scientific). The appropriate volume of cells was then

removed from the flask and centrifuged in a 50 mL conical tube at 2,500 rpm for 3
minutes. The media was decanted and the pellet was resuspended in 15 mL Phosphate
Buffered Saline (PBS). The cells were centrifuged again at 2,500 rpm for 3 minutes, and
the supernatant was decanted. The cells were resuspended in an appropriate volume of
Complete Schneider’s Media to obtain 2 x 106 cells in 1.6 mL media for a 6-well plate,
or 1 x 106 cells in 0.8 mL media for a 12-well plate. 1.6 mL of resuspended cells were
seeded into each well of a 6-well plate, or 0.8 mL of resuspended cells in each well of a
12-well plate.
Plasmid Design for S2 Cell Dual-Luciferase Experiments
Leslie Rozeboom designed each of the constructs for inserting miRs -9A, -9B, 9C, -315 into S2 cells, as well as the reporter Firefly Luciferase-Futsch 3’UTR. Briefly,
the Futsch 3’UTR was PCR-amplified from a BAC vector from the Drosophila Genomics
Resource Center (DGRC), then cloned into pENTR using to TOPO Reaction for Gateway
system (Invitrogen), and then inserted into pAc5.1-FireflyLuciferase-Invitrogen Gateway
Reading Frame Cassette A using the LR Recombination from the Invitrogen Gateway
system. The Renilla Luciferase vector was generated similarly, with an SV40 3’UTR in
place of the Gateway Reading Frame Cassette. Each miRNA expression vector was
generated by PCR-amplifying 100-200 base-pairs upstream and downstream of the pre-
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miRNA sequence found on miRBase.org from w1118 larval genomic DNA and inserting
into pENTR using the TOPO Reaction for Gateway system (Invitrogen), and then inserted
into pAc5.1: Gateway Reading Frame Cassette A using LR Recombination from the
Invitrogen Gateway system. To generate the Empty Vector used for a negative control,
the Reading Frame Cassette was cut out of the pAc5.1-Reading Frame Cassette A vector
and the vector was re-ligated together (Rozeboom, 2011).
Reporters for the miR-9 and miR-315 sponges were designed by PCR-amplifying
the miR-9 sponge from pBSTM the miR-315 sponge from pBSTM using primer
sequences:

5’-CACCCTCACTAAAGGGAACAAAAGC-3’ and 5’- CGGGCC

CGGGATCCGATA-3’. Each sponge construct was then cloned into pAc5.1-Reading
Frame Cassette A for expression of the sponge constructs, and pAc5.1-Firefly LuciferaseReading Frame Cassette A for a sponge reporter, using the Gateway Cloning System
(Invitrogen).
An FMRP overexpression vector was generated by PCR-amplification of DFmr1
from

cDNA

plasmid

LD09557

(DGRC)

using

primer

sequences

5’-

CACCATGGAAGATCTC CTCGTGGA-3’ and 5’-TTAGGACGTGCCATTGACCA3’ followed by insertion into pENTR and subsequently into pAc5.1-Reading Frame
Cassette A using the Gateway System (Invitrogen).
The Futsch sequence was obtained from Flybase.org (St. Pierre et al., 2014). All
of the Futsch coding sequence fragment reporters were generated using the primers listed
in Table 1. Each fragment was PCR-amplified from w1118 larval genomic DNA, then
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inserted into pAc5.1-Firefly Luciferase-Reading Frame Cassette A using the Gateway
System. Nathan Boin performed most of these cloning reactions.

Table 1: PCR-Amplification of Futsch Coding Sequence Fragments
Futsch CDS
Fragment Name
A

Forward PCR Primer

Reverse PCR Primer

5’-CACCGATTCCTCTCCTG 5’-CCTTCCGGTTGTTGGCC-3’
GGACGTTT-3’
B
5’-CACCTGCTCGAGTCCA
5’-TTGGCTGATTTGGGTGGCAGCAGC-3’
3’
C
5’-CACCATCCGATGATGA 5’-AAGGAGATTTTTCGGCCA
GCTTCCTG-3’
CT-3’
D
5’-CACCAGTGGCCGAAAA 5’-CCTTCAAAACTTGCGGTG
ATCTCCTT-3’
AT-3’
E
5’-CACCATCACCGCAAGT 5’-TGGTCTGGAAACTTCCTT
TTTGAAGG-3’
GG-3’
F1
5’-CACCATCACAGGCAGC 5’-TCGCCTTGATTCTTCTTTG
CATAAAGC-3’
G-3’
F2
5’- CACCTGCAGAAAGTGT 5’- AGGCTGTATGCCCAGTAT
TCAGGACG-3’
CG-3’
G
5’-CACCAGGCGGAGAGTA 5’-TTCAGTGCTGAAGGCTTC
TCAAGGGT-3’
CT-3’
H
5’-CACCAGCCACTAAGTC 5’-CTGCATTTCCAGAGACTT
GGCCGA-3’
AAGCTC-3’
I
5’-CACCACTCGCAGGAG
5’-CCAACTCCTTGTCCTCC
CAG-3’
CAT-3’
J
5’-CACCAGGTCACCATT
5’-CTAGAACTCTAGGCGG
ATACCTACGTACGAC-3’
TAGGCC-3’
Fragments column of the Futsch coding sequence labeled according to the left column
were PCR-amplified from w1118 genomic DNA using the primers listed, then inserted
into pENTR then pAc5.1-Firefly Luciferase using Gateway cloning.
The Futsch 5’UTR reporter was generated using primer sequences 5’GCATTCGGTACCTCAGCTGTTCGGCTCCGCTT-3’ and 5’-GCATTCGAATTCTT
GGACGTGGATTAGCTGTGC-3’ from w1118 larval genomic DNA, cut with
restriction enzymes KpnI and EcoRI then cloned into pAc5.1-Firefly Luciferase-Futsch
3’UTR upstream of Firefly Luciferase using standard cloning techniques.
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All plasmid sequences were verified by sequencing from the University of
Colorado DNA Sequencing and Analysis Core.
Dual Luciferase Assay
Transfection mixtures were prepared using the Qiagen Effectene Transfection
Reagent Kit according to the instructions from Qiagen. Each construct for the DNA
mixture was prepared using an endotoxin-free maxi-prep (Qiagen or Promega). DNA
mixtures were prepared as follows: 0.1 g Firefly Luciferase-Target constructs, 0.4 g
Renilla Luciferase, 0.5 g miRNA overexpression or sponge construct, empty vector
control, or FMRP expression construct, per transfection for a 6-well experiment. For a
12-well experiment, each of these quantities was cut in half. DNA mixtures were prepared
in triplicate in a total volume of 300 l EC Buffer. To each mixture, 24 l Enhancer was
added for a 6-well experiment, or 12 l Enhancer for a 12-well experiment, and mixed
by flicking. Each mixture was then incubated for 3 minutes at room temperature. Next,
to each mixture, 30 l Effectene reagent was added for a 6-well experiment, or 15 l
Effectene reagent for a 12-well experiment, and mixed by vortexing for 10 seconds. The
mixtures were incubated at room temperature for 7 minutes, during which they were
transferred to a sterile hood containing the seeded 6-well or 12-well plates. At the end of
the incubation, 3 mL Complete Schneider’s Media was added to each mixture for a 6well experiment, or 1.5 mL Complete Schneider’s Media for a 12-well experiment, and
mixed by pipetting up and down. 1.1 mL of each mixture was added drop-wise to each of
3 wells (biological triplicate) containing the SL2 cells on the 6-well plate while swirling
the plate; half the volume for a 12-well experiment.
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Each 6-well or 12-well plate was placed in a lidded plastic box to prevent
contamination of the cells, and each box was in turn placed in an incubator at room
temperature for 72 hours. At the end of the 72-hour incubation, cells were scraped from
the bottom of the plate using a p1000 micropipettor tip. The cells from each well were
then pipetted up and down to thoroughly and homogeneously resuspend them. Next, 75
µl of resuspended cells from each well of the 6-well or 12-well plate were added to each
of 3 separate wells (technical triplicate) of a 96-well plate (CoStar). To each of these wells
was then added 75 µl Dual-Glo Luciferase Reagent from the Dual-Glo Luciferase Assay
System (Promega). This was added as simultaneously as possible using a multi-channel
micropipettor. The plate was allowed to incubate for 10 minutes in a foil-covered box, as
the reagent is light-sensitive. The 96-well plate was then placed in a Synergy HT
microplate reader and luminescence was quantified as Firefly Luciferase luminescence.
Next, 75 l Dual-Glo Stop and Glo Reagent from the Dual-Glo Luciferase Assay System
(Promega) was added to each cell-containing well of the 96-well plate, and the plate was
immediately placed into the microplate reader again, this time to quantify Renilla
Luciferase luminescence.
Normalized FLuc/RLuc ratios were determined by an Excel spreadsheet I
designed. Briefly, a Firefly Luciferase to Renilla Luciferase (FLuc/RLuc) ratio was
generated for each well by dividing the raw FLuc value obtained from the microplate
reader by the raw RLuc value obtained from the microplate reader. Next, an average was
taken for each set of 3 technical replicates (each biological replicate) by using the
“Average” function in Excel. The ratio for each experimental set was then normalized to
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the empty vector control by dividing each averaged biological replicate FLuc/RLuc ratio
by an average of all 3 biological replicates of the empty vector control. Statistics were
calculated using ANOVA in Prism.
Protein Extraction
For the protein extraction from fly head extract followed by qRT-PCR, w1118
flies were aged 3-5 days, then flies were anesthetized with carbon dioxide gas, poured
into a tube on ice, then frozen on liquid nitrogen for preservation of tissue. The tube
containing frozen flies was then vortexed 15-30 seconds, then poured onto the top of two
stacked mesh filters previously frozen with liquid nitrogen. The filters were tapped for up
to 30 seconds. Wing, leg, and other small particles fell through both filters, while heads
remained between the first and second filter, and the large bodies remained on the top of
the first filter. All heads from between the first and second filter were funneled into a
frozen 2 mL round-bottom tube, then homogenized using a TissueRuptor (Qiagen) in
Buffer TBT (Dokudovskaya et al., 2006) containing Superase RNase Inhibitor
(Invitrogen), and antifoam B (Sigma), and Solution P as indicated in Oeffinger et al.
(2007), which includes PMSF, which we substituted with EDTA-free protease inhibitor
tablets (Roche), and Pepstatin A (Fisher Scientific). Homogenate was centrifuged at
3,000 x g for 3 minutes and the supernatant was flash-frozen on liquid nitrogen and stored
at -80°C to be used for downstream applications.
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Immunoprecipitation Followed by qRT-PCR
All materials for the following procedure were kept on ice when not at 4°C on a
rotator. All materials and reagents were RNase-free and all work was performed in an
RNA hood sprayed down with RNase-Away (Molecular BioProducts) and dried.
Immunoprecipitation
Protein G-coated magnetic beads (Invitrogen) were washed 3 times with 1X PBS
plus 0.2% Tween, and then half of these beads were blocked with 100 μg/mL yeast tRNA
diluted in 1X PBS + 0.02% Tween. Half of these pre-blocked beads were applied to three
extracts, each containing 100 μg of w1118 protein extract, to pre-clear the protein
samples. The other half of the pre-blocked beads were used downstream for the “beads
only” immunoprecipitation. Half of the unblocked Protein G-coated magnetic beads were
incubated with antibody Mouse IgG (Invitrogen), and half with Mouse anti-DFmr1
(6A15; Abcam) for 10 minutes at 4°C, then blocked with 100 μg/mL yeast tRNA diluted
in 1X PBS + 0.02% Tween for 30 minutes at 4°C. These beads were then washed 4 times
with Buffer TBT containing 10 μg yeast tRNA, and each was then incubated with precleared 100 μg of w1118 protein extract for 2 hours at 4°C. The additional pre-cleared
extract was incubated for 2 hours at 4°C with the pre-blocked beads that had not been
incubated with antibody (described earlier). All beads were then washed 4 times with
Buffer TBT and protein was eluted using 180 μl of 100 mM Glycine-HCl [pH 2.8]. 20 μl
of 1M Tris [pH 7.5] was added to each tube of eluted protein to neutralize the pH before
proceeding to RNA Isolation.
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RNA Isolation from Eluted Extract
Samples were allowed to return room temperature. Next 60 μl chloroform was
added to each sample; samples were mixed thoroughly, incubated for 2-3 minutes, then
centrifuged at 12,000 x g for 15 minutes. The upper aqueous phase was transferred to a
new tube, to which was added 1 volume of 100% ethanol. After mixing, each sample was
transferred to an RNeasy spin column (Qiagen). RNA was then extracted using the
RNeasy Mini Kit from Qiagen following manufacturer’s instructions, and stored at
-80°C for use in later qRT-PCR analysis.
qRT-PCR analysis
RNA was precipitated using an ethanol precipitation and the visualization agent
GlycoBlue (Ambion). RNA was converted to cDNA using the Qiagen miScript Reverse
Transcription for Quantitative Real-Time PCR Kit by following manufacturer’s
instructions. qRT-PCR was then performed on each extract using the miScript SYBR
Green PCR Kit and miScript primer assays (Qiagen) for miRs -9A, -9B, -9C, -315, and
small RNA U1 using two technical replicates per reaction in a 96-well plate. One replicate
containing only water was included for each reaction as a negative control. PCR was
performed on the iCycler Thermocycler (BioRad) and fluorescence was read by the iQ5
Multicolor RT-PCR Quantification System (BioRad) and quantified using the iQ5
Optical System Software version 1.2.
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Chapter 2.3: Analyzing the Effects of miRNA Expression on NMJ Structure
Generation of Transgenic Fly Lines
Overexpression and Under-Expression Fly Lines for miRs -9A, -9B, -9C and -315
Using the Gateway Cloning System, Leslie Rozeboom inserted the same
sequences used for overexpression of each of miRs -9A, -9B, -9C, and -315 into a
pUASM-mCherry-RFB vector. These plasmids were sequenced, maxi-prepped using a
Qiagen Maxi-Prep Kit, and sent to BestGene for insertion into fly lines and balancing.
Using the Gateway Cloning System, the same miR-9sponge(15x repeat) and miR315 sponge(20x repeat) sequences used in S2 experiments were inserted into pUASMmCherry-RFB, sequenced, maxi-prepped using the Promega Maxi-Prep Kit, and sent to
BestGene for insertion into fly lines. The miR-315 sponge lines were balanced by
BestGene. Due to a BestGene error, the miR-9 sponge lines were balanced by me. To do
this, flies were first examined for a transgene on the sex chromosome, knowing that in
the generation of flies we received, if a transgene was X-linked, females would express
the transgene and not males. None of the lines contained an X-linked transgene. To
balance the miR-9 sponge lines, I crossed males from each transgenic line, which
expressed the Mini-white gene, to the BL 7199 (Bloomington) line, which expresses
Kruppel/Curly-wing; Tubby-Stubble/Dichaete (Kr/CyO; TbSb/DI). Red-eyed, curlywing, stubble adult offspring were isolated and back-crossed to the BL 7199 line again.
Flies containing the transgene on the second chromosome would have red eyes, and could
not be both kruppel and curly-winged, so if a line showed this, a male was isolated, and
a virgin female with the mini-white and curly-wing phenotypes, and also TbSb/DI (when
possible) for a single-pair mating to generate a stable double-balanced line. On the other
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hand, flies containing the transgene on the third chromosome would have red eyes, and
could not be both tubby-stubble and dichaete, so if a line showed this, a male was isolated,
and a virgin female with the mini-white and tubby-stubble phenotypes, and also Kr/CyO
(when possible) for a single-pair mating to generate a stable balanced (or doublebalanced) line.
To perform analyses using more than one copy of a sponge transgene, doublemiRNA sponge lines were generated. To do this, double-balanced miR-315 sponge lines
were first generated by crossing males from the miR-315 sponge lines previously
analyzed to BL 7199 virgin females. Male offspring expressing mini-white, curly wings,
and stubble were isolated and back-crossed to BL 7199 virgin females. Offspring that
were either transgene/CyO; TbSb/DI for transgenes on the second chromosome, or
offspring that were Kr/CyO; transgene/TbSb for transgenes on the third chromosome
were isolated. When transgenic lines were viable as homozygotes, the homozygotes were
isolated. Single-pair mating for each double-balanced transgenic line were performed a
to generate the following: Kr/CyO; UAS: mCherry-miR-315sp(20x)(Line 1)/TbSb,
Kr/CyO; UAS:

mCherry-miR-315sp(20x)(Line 2)/TbSb, and UAS: mCherry-miR-

315sp(20x)(Line 6) on II; TbSb/DI.
To generate double-sponge lines, the following crosses were performed:
UAS: mCherry-miR-315sp(20x) (Line 6) on II; TbSb/DI x
Kr/CyO; UAS: mCherry-miR-315sp(20x) (Line 1) /TbSb,
UAS: mCherry-miR-315sp(20x) (Line 6) on II; TbSb/DI x
Kr/CyO; UAS: mCherry-miR-315sp(20x) (Line 2) /TbSb,
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UAS: mCherry-miR-315sp(20x) (Line 6) on II; TbSb/DI x
Kr/CyO; UAS: mCherry-miR-9sp(15x) (Line 2) / TbSb
UAS: mCherry-miR-315sp(20x) (Line 6) on II; TbSb/DI x
Kr/CyO; UAS: mCherry-miR-9sp(15x) (Line 5) / DI
UAS: mCherry-miR-9sp(15x) (Line 1)/CyO ; TbSb/DI x
Kr/CyO; UAS: mCherry-miR-9sp(15x) (Line 2) / TbSb
UAS: mCherry-miR-9sp(15x) (Line 1)/CyO ; TbSb/DI x
Kr/CyO; UAS: mCherry-miR-9sp(15x) (Line 5) / DI
Non-kruppel, non-dichaete, curly-winged, stubble offspring were selected and
mated. When possible, offspring with homozygous expression of a transgene were
selected for single-pair matings. Otherwise, single-pair matings were performed with
heterozygous-expression offspring.
Fly Crosses Performed for NMJ Analysis
For overexpression of miRs -9A, -9B, -9C, and -315, virgin female
P{w[+mW.hs]=GawB}elav[C155] flies were crossed to males from each of the following
lines: UAS: mCherry-miR-9A (Line 1)/Tm3Sb, UAS: mCherry-miR-9A (Line 2)/CyO,
UAS: mCherry-miR-9B (Line 1)/ CyO, UAS: mCherry-miR-9B (Line 2)/Tm3Sb,
mCherry-miR-9C (Line 1)/ CyO, UAS: mCherry-miR-9C (Line 3)/Tm3Sb, UAS:
mCherry-miR-315 (Line 1)/CyO, UAS: mCherry-miR-315 (Line 2)/ CyO. Another
overexpression experiment was performed by crossing males from the same miR-9 and
miR-315 overexpression transgenic lines each to C380-Gal4 virgin females. In both
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cases, larvae demonstrating overexpression of the transgene were isolated by examining
them for mCherry expression using an Olympus SZX10 Research Stereo Microscope.
For under-expression of miRNAs, virgin female C380-Gal4 flies were crossed to
males

from

the

following

transgenic

fly

lines:

UAS:

mCherry-miR-

9sp(15x)(Line1)/CyO; TbSb/DI, Kr/CyO; UAS: mCherry-miR-9sp(15x)(Line 2)/TbSb,
and Kr/CyO; UAS: mCherry-miR-9sp(15x)(Line 5)/DI. In both cases, larvae
demonstrating expression of the transgene were isolated by examining them for mCherry
expression using an Olympus SZX10 Research Stereo Microscope. Larvae displaying the
Tubby phenotype were also selected against to avoid complications involving larval
shape.
NMJ Analysis: Dissection, Staining and Imaging
NMJ analysis was performed on each cross first by vivisecting the larvae. This
was done by pinning larvae at the posterior and anterior to a Sylgard plate in hemolymphlike 3 buffer (HL-3; Stewart et al., 1994), cutting the larvae open, removing the guts and
CNS, then pinning each larva open at 2 points along either side of the mid-section. These
preps were fixed for 20 minutes in 3.5% paraformaldehyde, washed 3 times for 10
minutes on a shaker with 1X PBS, then once with 1X PBS plus 0.1% Triton X-100. Preps
were blocked for 1 hour at room temperature, then incubated with a 1:100 dilution (in
block) of the primary antibody Mouse anti-Discs Large either at 4˚C overnight or for 2
hours at room temperature. Preps were then quick-washed twice with 1X PBS plus 0.1%
Triton X-100, then 6 times for 10 minutes on a shaker. They were then incubated for 1
hour at room temperature with a 1:100 mixture (in block) of Goat anti-HRP_Dylight649
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and 1:500 mixture of Goat anti-Mouse_AlexaFluor488. Preps were quick-washed twice
with 1X PBS plus 0.1% Triton X-100, then twice for 10 minutes on a shaker. Finally,
preps were rinsed for 10 minutes on a shaker with 1X PBS and retained in 1X PBS at 4˚C
no more than a day until they could be mounted.
Preps were mounted onto slides by removing the pins and blotting the preps dry
with a Kimwipe applied to the posterior end, then adding a drop of VectaShield (Vector
Laboratories) containing DAPI to a glass slide and placing the preps gently on the slide.
Each prep was covered with a glass coverslip and the coverslip was secured using clear
nail polish. Preps were imaged on an Olympus FV1000 Scanning Confocal microscope
at a 100X magnification. Fluoview software was used to distinguish fluorescence by
coloring the 649 fluorescence with red, and the 488 fluorescence with green.
NMJ Analysis: Quantification of Boutons and Morphology Analysis
Images from each experiment were scrambled and blindly analyzed for the
number of 1B and 1S boutons, terminal tips, etc. using the Cell Counter analysis function
of the program ImageJ. Data were then compiled and analyzed in the program Prism for
mean and standard error calculations.
For analysis of Bouton morphology, colored channels were separated in ImageJ
and the red channel was used for morphology analysis. Boutons were circled using a
hand-drawing tool, and the ROI manager was used to quantify various aspects of the
circled areas, including Area, Roundness, and Feret’s Diameter.
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Chapter 2.4: Analyzing the Effects of P-Bodies and Their Interactions with DFmr1
on Synaptic Structure
For crosses investigating the interactions between FMRP and P-body
components, or the role of P-body components themselves, see Table 2. Larvae were
dissected, stained, and imaged as previously described (2.3 “NMJ Analysis: Dissection,
Staining and Imaging”).
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Table 2: Genetic Fly Crosses Performed to Analyze the Role of P-Body
Components In Affecting NMJ Structure
Virgin Females
CantonS
w1118 (Iso31)
w1118 (Iso31)
w1118 (Iso31)
Pat1[Δ3]/Tm3SerGFP
Pat1[Δ3]/Tm3SerGFP
Pat1[Δ3]/Tm3SerGFP
w1118; DFmr1[Δ113M]/TM6B,
Tb[1]
w1118 (Iso31)
w1118 (Iso31)
w1118 (Iso31)
w1118 (Iso31)
w1118 (Iso31)
w1118 (Iso31)
w1118; DFmr1[Δ113M]/TM6B,
Tb[1]
w1118; DFmr1[Δ113M]/TM6B,
Tb[1]

Males
w1118 (Iso31)
Pat1[Δ3]/Tm3SerGFP
w1118; DFmr1[Δ113M]/TM6B,
Tb[1]
w1118; DFmr1[Δ50M]/TM6B, Tb[1]
w1118; DFmr1[Δ113M]/TM6B,
Tb[1]
w1118; DFmr1[Δ50M]/TM6B, Tb[1]
Pat1[Δ3]/Tm3SerGFP
w1118; DFmr1[Δ50M]/TM6B, Tb[1]

Selection
Markers
None
GFP
Tubby
Tubby
GFP, Tubby
GFP, Tubby
GFP
Tubby

Me31BΔ1, FRT40A/CyOGFP
Me31BΔ2,FRT40A/CyOGFP
y[1] w[67c23];
P{w[+mC]=GSV6}twin[GS12209] /
Tm6C,Sb,Tb
y[1] w[67c23];
P{w[+mC]=GSV3}twin[GS8115] /
Tm6C,Sb,Tb
dDcp1b53/CyOGFP; T3/Tm6*
W;FRTG13,Dcp1442P/CyOGFP
Me31BΔ2,FRT40A/CyOGFP

GFP
GFP
Tubby

y[1] w[67c23];
P{w[+mC]=GSV6}twin[GS12209] /
Tm6C,Sb,Tb
W;FRTG13,Dcp1442P/CyOGFP

Tubby

Tubby
GFP
GFP
GFP, Tubby

GFP, Tubby
w1118; DFmr1[Δ113M]/TM6B,
Tb[1]
GFP
Me31BΔ2,FRT40A/CyOGFP
Me31BΔ1, FRT40A/CyOGFP
Tubby
y[1] w[67c23];
y[1] w[67c23];
P{w[+mC]=GSV6}twin[GS12209] P{w[+mC]=GSV3}twin[GS8115] /
/ Tm6C,Sb,Tb
Tm6C,Sb,Tb
442P
GFP
W;FRTG13, Dcp1 / CyOGFP
dDcp1b53/CyOGFP; T3/Tm6*
Fly crosses were performed as detailed above, and larval offspring were selected by
selecting against the marker(s) indicated.
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*To generate this fly line, I first had to generate a double-balancer line containing the
larval marker GFP. To do this, I crossed males from the line Inversion/CyOGFP
(Inv/CyOGFP) to virgin female BL 7199 Kr/CyO; TbSb/DI flies, isolated red-eyed males
expressing curly-wings and stubble, and back-crossed these to BL 7199 virgin females. I
performed a single-pair mating to get a stable line of Kr/CyOGFP; TbSb/DI flies. I then
crossed virgin females of these flies to males from the existing dDcp1b53/CyOGFP;
T3/Tm6 line as described above.
Chapter 2.5: Expression of Tagged P-Body Components in S2 Cells
For expression of tagged P-body components in S2 cells, each component was
cloned into the pAc5.1: V5-HisA using standard cloning techniques. See Table 3 for
details.
Table 3: Cloning of P-Body Components into pAc5.1: V5-HisA
P-Body
Protein

cDNA
Used

Forward Primer

Reverse Primer

Restriction
Enzymes
NotI, XbaI

5’-GCATTCGCGGCC
5’-GCATTCTCTAG
GCATGATGACTGAA ATTTGCTAACGTTG
AAGTTAAATTC-3’
CCCTCCT-3’
5’-GCATTCGGTACC
5’-GCATTCGAATT
KpnI,
Twin
LD18435 ATGAAAGGCAATCA CCCGGCGATTGAT
EcoRI
T-3’
CAGCCCG-3’
5’-GCATTCGCGGCC
5’-GCATTCTCTAG
NotI, XbaI
HPat
RE36948 GCATGGATGACTCG AATCAATTTGATGC
TT TTTCGGC-3’
CTGGCTTC-3’
5’-GCATTCGGTACC
5’-GCATTCGAATT
KpnI,
Dcp1
GH04763 ATGGCCGACGAGAG CTTGATATGTGGAG EcoRI
CATCA-3’
CTGGAGTCCAGC-3’
Each P-body component was PCR-amplified from a cDNA from the Drosophila
Genomics Resource Center (DGRC) listed using the primers listed, which did not include
the stop codon for any of the sequences. Sequences were cloned into pAc5.1: V5-HisA
from Invitrogen using the restriction enzymes listed to insert each sequence upstream and
in-frame with the V5 and His tags. Constructs were verified by sequencing.
Me31B

LD21247

Chapter 2.6: Stable Expression of FLAG-HA-FMRP in S2 Cells
The vector pENTR: DFmr1 had previously been generated (Chapter 2.2, “Plasmid
Design for S2 Cell Dual-Luciferase Experiments”). Using the same Gateway Cloning
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Technique, an LR Recombination reaction was used to insert the DFmr1 sequence into
the vector pAFHW from the Drosophila Genomics Resource Center (DGRC), in-frame
with a 3x-FLAG, 3x-HA tag. Once the sequence was verified and overexpression of
FMRP was tested by transfection into S2 cells using the Qiagen Effectene Transfection
Reagent Kit, a stable-expression S2 cell line was generated.
To generate a stable-expression S2 line for permanent expression of pAFHWDFmr1, 3.8 g of pAFHW-DFmr1 and 0.2 g pCoBlast—a plasmid conferring cellular
resistance to the eukaryotic cell antibiotic Blasticidin—(Invitrogen), were transfected into
1 x 106 S2 cells each of 2 wells in a 6-well plate (CoStar) using Effectene as described
previously (Chapter 2.2 “Dual-Luciferase Assay”). Cells were allowed to grow for 72
hours, at which point, the media was gently siphoned from the cells, and cells were
dislodged by roughly pipetting with fresh Complete Schneider’s Media plus 12.5 g/mL
Blasticidin. Resuspended cells were transferred to a new 6-well plate and allowed to grow
to optimal density over the course of 1-2 weeks. Cells were maintained by siphoning off
media every 3-4 days and replacing with fresh media. Once cells had reach optimal
density in a 6-well plate, they were transferred to a 25 cm2 coated culture flask (CellTreat)
and allowed to grow to optimal density again before transfer to a 75 cm2 coated culture
flask (CellTreat). At this point, some of the cells were frozen following protocols from
the Drosophila RNAi Screening Center (DRSC), while others were tested for expression
of the tagged FMRP.
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Chapter 2.7: Overall Western Blot Procedures
Fly Head Extracts Preparation
Extracts from fly heads were prepared using Buffer TBT as described previously
(Chapter 2.2 “Protein Extraction”). Samples were quantified using the BioRad RC DC
Protein Assay Kit as per manufacturer’s instructions. Measured quantities of protein
extract were combined with Laemmli Sample Buffer (BioRad) in at least a 1:1 ratio, to
which was added 10% 1M Dithiothreitol (DTT) by volume.
S2 Cells Protein Sample Preparation
S2 cell protein extracts were prepared by scraping cells from an adherent plate
using a p1000 pipet tip. Cells were then transferred to a microcentrifuge tube and
centrifuged at 3,000 x g for 3 minutes. Supernatant was pipetted off and additional cells
from the same well were added. This process was repeated until all cells from all wells
were spun down and the supernatant was pipetted off. Cells were washed in 1X PBS, then
resuspended in NET Buffer (Huntzinger et al., 2010) plus Solution P (Oeffinger et al.,
2007) where we substituted EDTA-free protease inhibitor tablets for PMSF, and Superase
RNase Inhibitor (Invitrogen) and incubated on ice for 10 minutes on ice. Lysates were
then centrifuged at maximum speed for 10 minutes, supernatant was aliquotted and flashfrozen on liquid nitrogen, and stored at -80°C for downstream applications.
Protein was quantified using the Pierce BCA Protein Assay as per manufacturer’s
instructions. Samples were prepared using BioRad 2X SDS/Laemmli Sample Buffer in
at least a 1:1 volume ratio with samples, to which was added a 10% volume of 1M DTT.
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Western Blot Protocol
For all Western Blot experiments, the following procedures were followed.
First, samples were separated by size using protein gel electrophoresis. Samples
were prepared on ice, then boiled at 95°C for 5 minutes, and replaced immediately on ice
before undergoing protein gel electrophoresis.
Afterwards, proteins were transferred to an Immun-Blot PVDF membrane
(BioRad) using the BioRad Mini Trans-Blot Apparatus. Transfer was set to 100V and
limited to 350 milliamps for 55 minutes.
For tagging of proteins on the membrane, the membrane was placed immediately
in Block Buffer (5% dry milk in 1X Tris-Buffered Saline [TBS] plus 0.1% Tween) for 1
hour in a pipet box lid on a slow shaker. Afterwards, primary antibody solutions were
prepared in fresh Block Buffer at their necessary dilutions. The protein membrane was
transferred to the inside of a plastic page protector, which was then sealed on 3 sides by
a Super-Sealer heat sealer (Traco). Sufficient antibody solution was pipetted over the
membrane and then the fourth side of the page protector was sealed, ensuring no bubbles
over the membrane. The membrane was taped to a fast shaker and placed at 4°C overnight
or at room temperature for 2 hours. The membrane was transferred to a pipet box lid, and
quick-washed twice in Wash Solution (1X TBS plus 0.1% Tween). Then the membrane
was covered in Wash Solution and placed on a shaker for 10 minutes; this procedure was
repeated twice. The membrane was then transferred to a new page protector using the
same procedure described previously, and a secondary antibody solution prepared in
Block Buffer was added to the membrane. The membrane was then placed on a fast shaker
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at room temperature for 1 hour. Washes using the same procedure described previously
were performed.
For imaging, Thermo Scientific SuperSignal West Dura Chemiluminescent
Substrate components were mixed in a 1:1 ratio and incubated on each membrane for 5
minutes. Substrate was drained and membranes were imaged using film and a Konica
Minolta Medical Film Processor (Model SRX-101A).
Chapter 2.8: Co-Immunoprecipitation of FMRP with P-Body Components
For co-immunoprecipitation experiments in S2 cells, 1 µg of each tagged P-body
component was transfected into the stable-expression pAFHW-DFmr1 S2 cells—except
for control cells, which did not receive a transfection mixture—as described previously
(Chapter 2.6, “Stable Expression of FLAG-HA-FMRP in S2 Cells”) using a 6-well plate.
Protein extracts were prepared and quantified as described previously (Chapter 2.7, “S2
Cells Protein Sample Preparation”). For the immunoprecipitation procedure, the Pierce
HA-Tag Magnetic IP/Co-IP Kit was used as per manufacturer’s instructions. Briefly, 25
µl magnetic beads were transferred to a 1.5 mL microcentrifuge tube, to which was added
175 µl NET Buffer. Beads were mixed briefly by vortexting, placed on a magnet, and
supernatant was removed. This wash process was repeated with 1 mL NET Buffer. Next,
110 µg samples for each protein were prepared in a 220 µl volume using NET Buffer on
ice. 20µl of each sample was saved at the 10% “input” on ice, while the remaining 200
µl were added to the magnetic beads. Tubes were placed on a rotator for 30 minutes, then
washed 3 times with 300 µl NET Buffer, and once with nanopure water. Protein was
eluted from the beads by adding 100 µl 1X Non-Reducing Sample Buffer to the beads,
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plus 5 µl of 1M DTT, then heating the samples at 95°C for 5 minutes. Each tube was
placed against a magnet for 2 minutes and the supernatant was transferred to a new 1.5
mL tube, which was immediately placed on ice. For input control, 5 µl of 5X NonReducing Sample Buffer was added to each tube, plus 1.1 µl 1M DTT. These were heated
at 95°C for 5 minutes, then placed immediately on ice. All samples then underwent the
same procedures described previously (Chapter 2.7, “Western Blot Protocol”).
Chapter 2.9:

Co-Localization Studies of FMRP and P-Body Components in
Primary Neuron Cultures From Drosophila Larvae

Primary Neuron Culture
For co-localization experiments, male flies expressing either YFP-tagged FMRP
or GFP-tagged HPat were crossed to virgin females expressing the C380 Cha-Gal80
driver for expression of the YFP-tagged FMRP in glutamatergic but not in cholinergic
neurons (Kuehn and Duch, 2013). Fluorophore-positive larvae were selected, and from
these, ventral ganglia were dissected in Complete Scheider’s Media plus 1X Normocin
(InvivoGen). At least ten ventral ganglia from each genotype were pooled for a single
experiment and incubated in a 1X Liberase DH Research Grade enzyme (Roche) solution
prepared in Rinaldini’s Saline for 1 hour. Cells were then transferred to Complete
Schneider’s Media plus 1X Normocin, washed 3 times in this solution by centrifugation
and removal of the supernatant, then triturated using a fire-polished glass pipet 55-60
times, and triturated using a p200 pipet tip 90-95 times. These solutions were then
pipetted onto a coated coverslip in a 35 mm poly-d-lysine coated glass-bottom petri dish
(MatTek) in a 200 µl volume. Cells were allowed to adhere for 1-2 hours before the
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solution was gently pipetted off and 2 mL fresh media was added. Each dish was allowed
to grow at room temperature for 3-5 days before fixation and staining.
Primary neuron cultures were fixed for 5 minutes in 4% paraformaldehyde, then
quick-washed twice with 1X PBS, and 3 times for 10 minutes each with 1X PBS,
followed by one time for 10 minutes with 1X PBS plus 0.1% Triton X-100. Cells were
then incubated with primary antibody solutions in block buffer overnight in a humid
chamber at 4°C. Primary antibody was washed off using 2 quick-washes followed by six
10-minute washes with 1X PBS plus 0.1% Triton X-100. Cells were then incubated with
secondary antibody for 1 hour in a humid chamber at room temperature, then quickwashed twice with 1X PBS plus 0.1% Triton X-100. Cells were then washed once for 10
minutes with 1X PBS and immediately imaged on the Olympus FV1000 Scanning
Confocal microscope.
Imaging and Image Analysis
Confocal images were thresholded (increased laser power) to exhibit maximum
fluorescence in granules for each fluorophore individually in neurites (oversaturated in
cell bodies), then overlapped in Adobe PhotoShop. Multiple neurons were imaged in each
primary culture dish. Co-localization was examined by visualizing a single channel in
black and white, and using a hand tool to circle discernible punctae. After circling all
punctae from a single neuron, the HRP image was overlaid to ensure circled punctae
resided within the neuronal structures. Next, both channels were turned back on, and the
number of punctae exhibiting overlap was counted and divided by the total number of
punctae circled. “Punctae” consisted of 6 pixels or more of a color grouped together
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unbroken. “Overlap” was defined as 33% yellow pixels in any punctae, or 33% of red
pixels in generally green punctae or 33% of green pixels in generally red punctae. From
each set of neurons from the same dish, a weighted average % co-localization was then
calculated.
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Chapter Three: Results
Chapter 3.1: Differential Expression of miRNAs in the Drosophila CNS of ThirdInstar Larvae Versus Adults
The goal of this research is to investigate the roles of RNP components, including
miRNAs, FMRP, and P-bodies, in synaptic structure. As stated previously, microRNAs
play a key role in synaptic development (Follert et al., 2014). Given this fact, it is
presumed that the most abundant microRNAs in a given tissue play the most critical role
in homeostasis for that tissue, and the targets of that tissue are therefore most important
in normal tissue function. Given that brain development underlies learning and long-term
memory, it is essential to understand which miRNAs contribute to this development.
Thus, we performed differential analysis on Drosophila larval CNS and adult brain to
learn what the most abundant miRNAs are at different developmental stages to better
understand how these miRNAs may contribute to learning and memory processes.
For the purposes of analyzing miRNA abundance in brain tissue, dissections were
performed to isolate brains from Drosophila larvae and adults. 100 CNS’s were dissected
out of w1118(Iso31) Drosophila larvae and 100 brains from adult flies; RNA was extracted
using Trizol, purified, and submitted for Next-Generation Sequencing (NGS) analysis.
Approximately 44 million reads from the larval extract and 50 million reads from the
adult extract were trimmed of the adapter sequences and filtered for quality, reducing the
numbers of reads to approximately 1 million reads for the larval extract and 1.2 million
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for the adult extract. These reads were then processed using the miRPIPE miRNA
quantification developed by Kuenne et al. (in press). Reads were converted to reads per
million, essentially converting each miRNA value to a percentage of the total miRNAs,
and quantification analyses were performed. Since we are interested in larval enrichment,
the number of normalized reads in the adult tissue were subtracted from the number of
normalized reads in the larval tissue and the results were graphed; for readability, only
the top and bottom 10 miRNAs are shown (See Figure 4); the full dataset can be viewed
in the Appendix (Figure A1). From this analysis, it is apparent that by far, the most
abundant and larvally-enriched miRNA is miR-315, followed closely by miR-184, then
miR-276A; these top three enriched miRNAs together comprise nearly 55% of the total
reads for larval miRNA expression. The next most enriched miRNAs in the larval CNS,
in order are: miR-92B, which comprises an additional 3.3% of the total reads in the larval
CNS, miR-10 (3%), miR-305 (2%), miR-9C (1.2%) and miR-995 (1.7%).

Figure 4: Differential Expression of miRNAs in Larval Versus Adult CNS
The expression of each miRNA was quantified and processed in Drosophila larval CNS
and adult brain using Next Generation Sequencing and miRPIPE. Each quantification
was normalized to reads per million in each tissue. The normalized reads in the adult
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brain was then subtracted from the normalized reads in the larval CNS. The top and
bottom ten larval-enriched miRNAs are shown.
When plotted against a linear regression assuming a 1:1 larva:adult ratio of
miRNA expression, all of these show significant deviation from that ratio (See Figure 4).
Interestingly, although miRs -315, -184, and -276A are by far the most numerically
enriched miRNAs in the CNS, the greatest fold-change for the top 15 most enriched
miRNAs in larval tissue was seen with miRs -92B and -92A, which showed over a 175fold increase each in abundance from adult tissue to larval tissue. The next greatest foldenrichments occurred in miRs -275, -9C, -315, and -9A, with fold-changes of 29-, 16-, 7, and 4-, respectively (see Table 4).

Figure 5: Differential Expression of miRNAs in Larval Versus Adult CNS
Compared to a Linear Regression
The miRNA quantifications were plotted onto a scatterplot with larval expression as the
x-axis and adult expression as the y-axis, then compared to a linear regression where x is
equal to y, assuming a 1:1 ratio of larval to adult expression for each miRNA. Those
points deviating most from the linear regression, or most abundant, are labeled.
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Table 4: Fold-Enrichment of the Top 15 Most Enriched miRNAs in the Larval CNS
miRNA
miR-92b
miR-92a
miR-275
miR-9c
miR-315
miR-9a
miR-306
miR-305
miR-10
miR-995
miR-993
miR-263a
miR-184
miR-31a
miR-276a

Abundance (Reads per Million)
33,138
2,349
6,478
11,192
103,160
3,263
2,896
14,073
19,839
10,531
2,646
2,172
102,191
2,024
76,265

Fold-Enrichment
197.51
175.39
28.94
15.57
7.03
4.19
3.64
3.29
2.94
2.64
2.43
2.19
1.77
1.67
1.64

Next, miRNA families were grouped together for the purposes of target analysis.
For example, the miR-9 family includes miRs -9A, -9B, and -9C, all of which share a
seed region binding sequence, which is why they comprise a miRNA family, but are
different at their 3’ ends, which is why they are considered different miRNAs. These were
grouped together because miRNA families share a seed region binding sequence, which
substantially increases the likelihood of these miRNAs binding to the same target
mRNAs. Each of the top 10 most larvally-enriched miRNAs/miRNA families was
analyzed for potential targets using TargetScanFly6.2 (http://www.targetscan.org
/fly_12/), which compares the seed region binding sequence of each miRNA/miRNA
family for complementarity to a mRNA target and analyzes most likely targets by
conservation of binding sites between different species of Drosophila. miR-315, the most
absolutely abundant and numerically enriched miRNA in the larval CNS, was predicted
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to regulate up to 417 target mRNAs. Number of potential targets varied significantly for
each miRNA (Table 5).
Table 5: Number of Predicted Targets for each of the Top 10 most Larvally-Enriched
miRNAs
miRNA
Number of Potential Targets
miR-315
417
miR-184
42
miR-276a
82
miR-92b
348
miR-10
11
miR-305
272
miR-9c
194
miR-995
54
miR-11
377
miR-275
46
To analyze the potential roles for each of these most abundant miRNAs, cluster
function annotation analysis was performed on each set of miRNA/miRNA family
potential targets using the Database for Annotation, Visualization and Integrated
Discovery (DAVID) program version 6.2 (http://david.abcc.ncifcrf.gov/home.jsp).
Interestingly, the potential targets for miR-315 showed a cluster with a large enrichment
score of 8.75 that included clusters for neuron development, neuron differentiation,
axonogenesis, etc., all with p-values less than 1x10-6 (see Table 6). The miR-9 family also
showed strong enrichment of this same cluster, with an enrichment score of 5.08 (Table
7), all with p-values less than 8.1 x 10-2. These were the only two miRNAs/miRNA
families to show their most enriched functional annotation clusters associated directly
with neuronal growth. In fact, of the ten most larvally-enriched miRNAs, only those and
miR-275, miR-11 and the miR-92 family showed a functional annotation cluster enriched
for neuron development with an enrichment score over 1.5 (Tables A1-A9).
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While the miR-92 family and miR-275 did show functional annotation clusters
including potential targets involved in neuron differentiation, dendrite morphogenesis,
etc. (See Supplementary Tables A1 and A2), the most enriched cluster for the miR-92
family included potential targets involved in transcription regulation, and miR-275 was
most predicted to target immunoglobulins. It is important to note that while the most
highly-enriched functional annotation clusters of miR-11 targets were not related to
neuron development, but rather to membrane development and transcription regulation,
there was a functional annotation cluster of miR-11 targets with an enrichment score of
3.47 that was similar to the most highly-enriched functional annotation clusters for the
miR-9 family and miR-315, including targets for neuron differentiation and development
(Table A9).
Table 6: Functional Annotation Cluster for Predicted miR-315 Targets
Enrichment Score 8.72
Cluster Name
Neuron development
Neuron differentiation
Cell morphogenesis involved in differentiation
Neuron projection morphogenesis
Neuron projection development
Cell morphogenesis involved in neuron
differentiation
Cell projection organization
Cell projection morphogenesis
Axonogenesis
Cell motion
Cell part morphogenesis
Cell morphogenesis
Axon guidance
Cellular component morphogenesis
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P-Value
1.30E-10
1.80E-10
3.20E-10
3.40E-10
3.80E-10
4.10E-10
5.10E-10
1.30E-09
1.30E-09
1.60E-09
2.80E-09
2.10E-08
2.30E-07
1.00E-06

Table 7: Functional Annotation Cluster for Predicted miR-9 Family Targets
Enrichment Score 5.08
Cluster Name
Cellular component morphogenesis
Cell morphogenesis
Cell morphogenesis involved in neuron
differentiation
Cell morphogenesis involved in differentiation
Neuron projection morphogenesis
Neuron projection development
Cell projection organization
Cell part morphogenesis
Neuron differentiation
Neuron development
Cell projection morphogenesis
Axonogenesis
Axon guidance
Dendrite morphogenesis
Dendrite development
Neuroblast proliferation

P-Value
6.80E-09
3.10E-08
4.30E-07
8.70E-07
2.00E-06
2.10E-06
2.60E-06
3.00E-06
3.20E-06
5.60E-06
8.40E-06
1.90E-05
6.10E-04
1.20E-03
1.20E-03
8.10E-02

Next, each of the miRNAs with target functional annotation clusters specific to
neuronal growth was analyzed (miRs -315, -275, -11, and the miR-92 and miR-9
families). Lists of the predicted targets for each of these miRNAs were cross-compared
using Microsoft Excel. Surprisingly, there was little overlap between the potential targets
for these miRNAs. Only ten targets were predicted to be regulated by 3 or more of these
miRNAs, and these targets did not form any functional annotation clusters with an
enrichment score over 1.5. There were 21 potential targets that overlapped between the
miR-9 family and miR-315, which showed a functional annotation cluster with an
enrichment score of 2.62 that included targets involved in actin cytoskeleton
reorganization (Table 8) and another functional annotation cluster with an enrichment
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score of 2.28 including targets involved in neuron differentiation, neuron projection
morphogenesis, etc. (Table 8). Similarly, six overlapping targets of miRs -315 and -275
showed a functional annotation cluster with an enrichment score of 1.97 that included
potential targets involved in neuron development, neuron projection morphogenesis, etc.
(Table 9). Lists of these potential targets can be found in the supplementary material
(Tables A10-A14).
In contrast, overlapping potential targets for miRs -315 and the miR-92 family are
strongly enriched in the transcription regulation category (Table A10); this is also the
most enriched annotation cluster for overlapping potential targets of the miR-9 family
and the miR-92 family (Table A11), and miR-11 and the miR-92 family (not shown).
Potential targets for miR-11 did not overlap with any of the other examined
miRNAs/miRNA families to form a functional annotation cluster pertaining to neuronal
growth. Similarly, other lists of overlapping targets did not show enrichment for
functional annotation clusters pertaining to neuronal development, differentiation, etc.
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Table 8: Functional Annotation Cluster for Predicted miRs -9 and -315 Targets
Enrichment Score: 2.65
Cluster Name
Cortical actin cytoskeleton organization

P-Value
2.30E-02

Cortical cytoskeleton organization
Cell projection organization
Actin cytoskeleton organization
Actin filament-based process
Cytoskeleton organization
Enrichment Score: 2.28
Cell projection organization
Neuron differentiation
Sensory organ development
Compound eye morphogenesis
Eye morphogenesis
Neuron projection morphogenesis
Neuron projection development
Cell morphogenesis involved in neuron
differentiation
Cell morphogenesis involved in
differentiation
Cell motion
Compound eye development
Cell projection morphogenesis
Cell part morphogenesis
Eye development
Neuron development
Regulation of cell morphogenesis
Cell morphogenesis
Cellular component morphogenesis
Axonogenesis
Cell projection organization
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2.30E-02
8.80E-02
1.50E-01
1.40E-01
4.50E-01
8.80E-02
9.00E-02
6.90E-02
1.20E-01
1.30E-01
1.30E-01
1.20E-01
1.10E-01
1.10E-01
1.00E-01
9.60E-02
9.90E-02
1.00E-01
9.70E-02
9.80E-02
1.10E-01
1.50E-01
2.10E-01
2.10E-01
8.80E-02

Table 9: Functional Annotation Cluster for Predicted miRs -275 and -315 Targets
Enrichment Score: 1.97
Cluster Name
Neuron projection morphogenesis
Neuron projection development
Cell morphogenesis involved in neuron
differentiation
Cell morphogenesis involved in differentiation
Cell projection morphogenesis
Cell part morphogenesis
Neuron development
Cell projection organization
Neuron differentiation
Cell morphogenesis
Cellular component morphogenesis
Neuron projection morphogenesis

P-Value
7.40E-03
7.40E-03
7.50E-03
8.30E-03
9.20E-03
9.80E-03
1.10E-02
1.20E-02
1.50E-02
1.70E-02
2.30E-02
7.40E-03

Ultimately, the analysis suggests that the most miRNAs most potentially involved
in synaptic development in Drosophila larvae are miRs -315, -275, and the miR-9 family.
The strong expression, enrichment, and functional cluster annotations emphasizing
neuronal growth and development suggests these miRNAs play a key role in synaptic
growth.
Chapter 3.2: Analyzing a Futsch Reporter as a Potential In vitro Target of LarvallyEnriched miRNAs
When analyzing the potential targets for the most enriched miRNAs in the larval
CNS by in silico analysis, a previous graduate student Leslie Rozeboom, noted that four
of the most abundant miRNAs are predicted to target the mRNA for Futsch, the
Drosophila homolog for mammalian MAP1B (Table A12). Thus, we investigated this
potential interaction by the in vitro analysis of a dual-luciferase assay. The initial
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experiment was performed by Leslie Rozeboom, who also generated all of the constructs
for this procedure. I later repeated the experiment to verify the results.
The Futsch 3’UTR was inserted into the 3’UTR region of Firefly Luciferase
(FLuc) to act as a reporter for Futsch expression. When miRNAs base-pair match to their
predicted targets, the RISC represses translation of the target, leading to down-regulation
compared to a control not regulated by the miRNA—Renilla Luciferase (RLuc; Figure
6A). Thus, the decreased FLuc/RLuc ratio is indicative of target repression. When S2
cells were transfected with miRNA overexpression vectors for miR-9A, miR-9B, miR9C, miR-315, or an empty vector control, along with the Futsch 3’UTR reporter, and
RLuc control, a statistically significant decrease in the FLuc/RLuc ratio was seen, in all
cases demarcating at least a 2-fold decrease in Futsch reporter expression (Figures 5CF).
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Figure 6: The miR-9 Family and miR-315 Specifically Regulate Translation of a
Futsch 3’UTR Reporter
(A) Cartoon of 3 constructs inserted into the S2 cells including the Futsch 3’UTR
reporter, and the model for repression by the miRNA base-pair matching to the target
mRNA containing the Futsch 3’UTR sequence and using the RISC to repress translation.
(B) Cartoon of 3 constructs inserted into S2 cells including the mutagenized Futsch
3’UTR reporter, and the model for de-repression by preventing base-pair matching and
subsequent binding of the miRNA to the target mRNA containing the Futsch 3’UTR. S2
cells were transfected with a Renilla Luciferase control, one of two reporters: an FLucFutsch 3’UTR construct (first two columns), or a mutagenized FLuc-Futsch 3’UTR
construct (last two columns), which was mutagenized at the binding site for either the
miR-9 family or miR-315, and finally, the cells were also transfected with either an empty
vector (control), or an overexpression construct for: (C) miR-9A, (D) miR-9B, (E) miR9C, or (F) miR-315. Cells were lysed and Firefly Luciferase and Renilla Luciferase
luminescence were quantified. Raw Firefly Luciferase values were normalized to raw
Renilla Luciferase ratios, the mean value for the empty vector control was calculated,
then the ratios were normalized to this mean value to demonstrate % change. Error bars
indicate mean ± SEM. Statistics: One-way ANOVA with a Dunn’s post-test. **p < 0.01,
*** p < 0.001 and **** p < 0.0001.
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To test the specificity of the interaction between each individual miRNA and the
Futsch reporter, we employed site-directed mutagenesis to alter the binding site for the
miRNA on the Futsch 3’UTR (Figure 6B). miRNA binding is dependent upon 100%
complementarity in the “seed region” binding sequence between the mRNA target and
the miRNA to induce translational repression. Thus, altering even a single nucleotide in
the seed region binding site on the target should prevent binding of the miRNA and lead
to de-repression of the target if the interaction is sequence-specific. In this case, Leslie
Rozeboom mutagenized three nucleotides in the seed region sequences. Only two
mutagenized constructs were required, as miRs -9A, -9B, and -9C share a seed region.
Upon expression of the Futsch reporter mutagenized at the miR-9 binding site along with
the RLuc control, and either an empty vector control, or overexpression construct for
miR-9A, miR-9B, or miR-9C, complete de-repression occurred (Figures 5C-E).
Similarly, expression of the Futsch reporter mutagenized at the binding site for miR-315
along with the RLuc control, and either an empty vector control, or overexpression
construct for miR-315 led to complete de-repression (Figure 6F).
Since overexpression of miRNAs -9A, -9B, -9C and -315 led to repression of a
Futsch reporter in vitro, we next sought to examine if decreased expression of these
miRNAs would lead to increased expression of a Futsch reporter. For this purpose,
miRNA “sponge” constructs were designed as outlined in Ebert et al. (2007). These
constructs express ten repeats of an ideal binding site for the miRNAs, such that the
miRNAs bind to this construct instead of their endogenous targets, thereby creating the
phenotypic effect of decreased miRNA expression (Figure 7A). The construct is designed
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with mismatches between the sponge and miRNA so that the miRNAs will act as
repressors of the target, but will not induce degradation of the sponge construct. Because
the miR-9 family shares a seed region binding site, we theorized that all of the miR-9
family should bind to a sponge designed for miR-9A. We chose to focus on miR-9A
because miR-9A precisely base-pair matches to human miR-9, making it a more relevant
target for human health implications (Li et al., 2006). To test the effectiveness of these
constructs, I altered the miR-9 sponge to express 15 repeats of the binding site, and the
miR-315 sponge to express 20 repeats of the binding site, then cloned these constructs
into a vector expressing the sponge construct downstream of Firefly Luciferase in the
place of the Firefly Luciferase 3’UTR under the control of an actin promoter for
expression in S2 cells. Then, each of these constructs was co-expressed with a Renilla
Luciferase control, and an empty vector control or overexpression vector for miR-9A,
miR-9B, miR-9C or miR-315, and FLuc/RLuc ratios were measured. Overexpression of
miR-9A and miR-9C with the FLuc-miR-9sponge vector demonstrated a significant
decrease in the FLuc/RLuc ratio compared to an empty vector control (Figure 7B), and
overexpression of miR-315 with the FLuc-miR-315sponge showed a significant decrease
in the FLuc/RLuc ratio compared to an empty vector control (Figure 7C). Interestingly,
overexpression of miR-9B with the FLuc-miR-9sponge did not lead to a significant
decrease in the FLuc/RLuc ratio, and even increased the FLuc/RLuc ratio above control
levels.
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Figure 7: The miRs -9A, -9C, and -315 Bind to Their Respective miR-9 or miR-315
Sponge Sequences in an in vitro reporter but miR-9B Does Not
(A) Cartoon depicting the transfection method and mechanism for a miRNA sponge
sequence reporter experiment (B) A 15X repeat of an ideal target sequence for miR-9A
or (C) a 20X repeat of an ideal target sequence for miR-315, was inserted into the 3’UTR
of a Firefly Luciferase reporter, then transfected into S2 cells with a Renilla Luciferase
plasmid, and either an empty vector (control) or an overexpression vector for (B) miR9A, miR-9B, miR-9C, or (C) miR-315. Cells were lysed and Firefly Luciferase and
Renilla Luciferase luminescence were quantified. Raw Firefly Luciferase values were
normalized to raw Renilla Luciferase ratios, the mean value for the empty vector control
was calculated, then the ratios were normalized to this mean value to demonstrate %
change. Error bars indicate mean ± SEM. Statistics: One-way ANOVA with a Dunn’s
post-test. **p < 0.01, *** p < 0.001 and **** p < 0.0001.
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Once the sponge sequences had been validated as targets for each of the miRNAs,
expression plasmids containing these sponge constructs were transfected individually
into S2 cells along with the Futsch 3’UTR reporter. An increase in FLuc/RLuc ratios
corresponding to increased Futsch 3’UTR reporter expression resulting from decreased
abundance of miRNAs was expected. Multiple trials with this experiment produced
varied results, none of which showed consistent increases in the FLuc/RLuc ratios in
response to transfection with the miR-9 or miR-315 sponges compared to empty vector
controls (Figures 7).

Figure 8: Transfection of S2 Cells with a miR-9 or miR-315 Sponge Does Not
Lead to Increased Expression of a Futsch 3’UTR Reporter
S2 cells were transfected with a Renilla Luciferase control, an FLuc-Futsch 3’UTR
reporter, and with either an empty vector (control), or an overexpression construct for the
miR-9sponge (15x repeat), or for the miR-315sponge (20x repeat). Cells were lysed and
Firefly Luciferase and Renilla Luciferase luminescence were quantified. Raw Firefly
Luciferase values were normalized to raw Renilla Luciferase ratios, the mean value for
the empty vector control was calculated, then the ratios were normalized to this mean
value to demonstrate % change. Error bars indicate mean ± SEM. Statistics: One-way
ANOVA with a Dunn’s post-test. *p < 0.05, **p < 0.01 and **** p < 0.0001.
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Chapter 3.3: Analyzing the Effects of Larvally-Enriched miRNAs on Drosophila
NMJ Structure In vivo
After demonstrating the effects of the miR-9 family and miR-315 on a Futsch
reporter in vitro, the next step was to test the effects of these miRNAs on Futsch in vivo.
To do this, C155-Gal4 driver flies (pan-neuronal Gal4 expression) were crossed to
transgenic flies designed by Leslie Rozeboom, which expressed the UAS construct
upstream of mCherry followed by the same miRNA sequences used in the S2 cells
experiments. Because we did not know which fly lines would produce the best
overexpression of each miRNA, the effects of miRNA overexpression for two transgenic
fly lines for each construct were tested. Overall, the number of 1B (“big”) boutons at
muscles 6/7 did not significantly decrease in response to pan-neuronal overexpression of
miRs -9A, -9B, -9C and -315 (Figure 9A) in either of the transgenic fly lines tested.
Similarly, neuronal overexpression of miRs -9A, -9B, -9C, and -315 had no effect on 1S
bouton quantities and therefore, total bouton counts were not affected (Figures 8B-C).
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Figure 9: Pan-Neuronal Overexpression of miRs -9A, -9B, -9C, or -315 Does Not
Decrease Bouton Numbers at Muscles 6/7 of the NMJ in Drosophila
Virgin flies containing the elav-C155-Gal4 driver were crossed to male flies containing
the transgene UAS: mCherry-miRNA construct for each of miRNAs -9A, -9B, -9C, and
-315. Third-instar larval offspring were screened for mCherry fluorescence, then
dissected, fixed, and stained with Mouse anti-Discs Large antibody followed by Goat
anti-Mouse AlexaFluorophore-488 and Goat anti-HRP-Dylight649 (far red). Muscles 6/7
from segment A3 were imaged on a confocal microscope, then the number of (A)1B, (B)
1S, and (C) total boutons were quantified. Error bars indicate mean ± SEM. Statistics:
One-way ANOVA with a Dunn’s post-test. **p < 0.01, *** p < 0.001 and **** p <
0.0001.
Futsch expression can affect not only bouton number at the Drosophila NMJ, but
also bouton size (Roos et al., 2000). Therefore, morphology analysis was performed on
the boutons of NMJs from the C155-Gal4 crossed to the miRNA overexpression lines.
The more promising of the two transgenic fly lines tested for each miRNA was chosen
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for this analysis. In other words, the transgenic lines that showed the greatest shift in
bouton number in response to pan-neuronal miRNA overexpression. Morphology
analysis revealed a very slight but statistically significant decrease in the total area of the
boutons resulting from overexpression of miR -9A, but no change in bouton roundness
or Feret’s Diameter. Additionally, there was no statistically significant increase in bouton
area, roundness, or Feret’s Diameter, in response to overexpression of miRs -9B, -9C, or
-315 (Figure 10A-9C).
A

B

C

Figure 10: Effects of Pan-Neuronal Overexpression of miRs -9A, -9B, -9C and 315 on Bouton Morphology at the Drosophila NMJ Muscles 6/7
Images utilized in Figure 9 were further analyzed. The red channel showing HRP staining
was split from the green channel showing Discs Large staining, and each individual
bouton was then circled in ImageJ and analyses were performed on bouton size using the
(A) Average area per bouton, and shape was analyzed using average (B) “Roundness”
and (C) Feret’s Diameter of each individual bouton. Error bars indicate mean ± SEM.
Statistics: One-way ANOVA with a Dunn’s post-test. **p < 0.01.
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Our lab has previously experienced difficulties with using the C155-Gal4 driver
in flies to examine phenotypes at the NMJ. Furthermore, it is possible that with panneuronal expression, the effects of overexpressed miRNAs would be masked by the effect
of neuronal feedback loops, which compensate for changes in mRNA expression.
miRNAs can be key components of these feedback loops (Ernsberger, 2012). Therefore,
the experiment of overexpressing miRs -9A, -9B, -9C, and -315 was repeated, this time
crossing the transgenic lines to the C380-Gal4 driver, which drives expression only in
motor neurons. Overexpression of miRNAs using the C380 driver resulted in a
statistically significant increase in the number of 1B boutons at muscles 6/7 for both miR9A overexpression transgenic lines that were analyzed, and for the first miR-315
overexpression transgenic line that was analyzed (Figure 11A); this was mimicked only
in the second miR-9A transgenic line in muscle 4 (Figure 11F). Overexpression of miR315 from the third transgenic line examined showed a decreased number in 1S boutons
(Figure 11B). However, this did not result in a statistically significant change in the total
number of boutons per NMJ at muscles 6/7, nor were significant changes observed from
overexpression of miRs -9A or -315 using any of the three transgenic lines examined at
muscles 6/7 (Figure 11C), at muscle 4 (Figures 11C-D), or in the number of terminal tips
per NMJ at muscle 4 (Figure 11F).
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Figure 11: Overexpression of miRs -9A and -315 in Motor Neurons Actually
Increases Bouton Numbers at Muscles 6/7 or Muscle 4 of the NMJ in
Drosophila Rather Than Decreases These Numbers
Virgin flies containing the C380-Gal4 driver were crossed to male flies containing the
transgene UAS: mCherry-miRNA construct for each of miRNAs -9A, -9B, -9C, and 315. Third-instar larval offspring were screened for mCherry fluorescence, then
dissected, fixed, and stained with Mouse anti-Discs Large antibody followed by Goat
anti-Mouse AlexaFluorophore-488 and Goat anti-HRP-Dylight649 (far red). Muscles 6/7
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(A-C) and 4 (D and E) from segment A3 were imaged on a confocal microscope, then the
number of (A)1B, (B)1S, and overall (C) boutons were quantified for muscles 6/7. (D)
Number of total boutons and (E) terminal tips were quantified for muscle 4. Error bars
indicate mean ± SEM. Statistics: One-way ANOVA with a Dunn’s post-test. * p < 0.05,
**p < 0.01 and **** p < 0.0001.
Overall, in vivo overexpression of miRs -9A and -315 induced statistically
significant changes in the number of 1B boutons at the NMJ for muscles 6/7 only using
the motor neuron driver C380; miR-9A overexpression also showed significant increases
in bouton numbers at muscle 4 using this same driver. Overexpression of these miRNAs
using a pan-neuronal driver did not appear to have significant effects on bouton size or
shape, and minimal, conflicting effects on bouton numbers were seen in response to miR315 overexpression in different transgenic lines using a motor neuron driver.
While overexpression of miRNAs of interest can potentially yield information
about the role those miRNAs play at the NMJ, knocking down expression is a far more
effective (and more physiological) method for examining miRNA function. Transgenic
fly lines expressing miRNA sponges for the miR-9 family, and miR-315 were therefore
generated, and crossed to a C380-Gal4 driver fly to induce miRNA knock-down for these
miRNAs in motor neurons. Analysis of the NMJ at muscles 6/7 revealed no statistically
significant change in the number of 1B boutons in response to the expression of a single
sponge construct for any of 3 transgenic lines examined for either the miR-9 family or
miR-315 (Figure 12A), though the second transgenic line for the miR-315 sponge yielded
a statistically significant decrease in the number of 1S boutons compared to controls
(Figure 12B) that resulted in a significant decrease in total boutons (Figure 12C). The
third transgenic line expressing a single copy of the miR-9 family sponge also showed
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significantly decreased 1S boutons (Figure 12B), but this did not affect total bouton
numbers (Figure 12C). When two copies of the miR-9 family sponge were expressed, this
led to a significant increase in the number of 1B boutons only (Figures 12A-C). None of
the significant changes in bouton numbers were mimicked in muscle 4, nor did underexpression of any of these miRNAs lead to a significant change in the number of terminal
tips per NMJ at muscle 4, though expression of the first miR-9 family sponge transgene
did result in a significant increase in bouton numbers at muscle 4 (Figure 12E).
Knockdown using a single construct for each of miRs -9 and -315 together did not induce
any significant effects at muscles 6/7 or at muscle 4.
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Figure 12: In vivo Knock-Down of miRs -9 and -315 Increases the Number of
Boutons at Muscles 6/7 and Muscle 4 of the NMJ in Drosophila
Virgin flies containing the C380 motor neuron driver were crossed to male flies
containing the transgene UAS: mCherry-miRNA sponge constructs for each of miRs -9
and -315. Third-instar larval offspring were screened for mCherry fluorescence, then
dissected, fixed, and stained with Mouse anti-Discs Large antibody followed by Goat
anti-Mouse AlexaFluorophore-488 and Goat anti-HRP-Dylight649 (far red). (A-C)

62

Muscles 6/7 and (D-E) muscle 4 from segment A3 were imaged on a confocal
microscope, then the number of (A) 1B, (B)1S, and (C) total boutons were quantified
from muscles 6/7. (D) Total boutons and (E) terminal tips were quantified from muscle
4. Error bars indicate mean ± SEM. Statistics: One-way ANOVA with a Dunn’s posttest. * p < 0.05, **p < 0.01 and *** p < 0.001.
Ultimately, decreased expression of miRs -9 and -315 had no more consistent
effects at muscle segment A3 muscles 6/7, or muscle 4 for any of the transgenic lines
examined than did overexpression. Statistically significant changes in 1B, 1S, and total
boutons were observed, but none significant enough to affect overall bouton count or to
remain consistent between the different muscles examined. However, miRNAs are
known to interact with other repression mechanisms, and overexpression or underexpression of miRNAs by themselves may not be enough.
Chapter 3.4: Investigating the Repression of Futsch by FMRP In Vitro
FMRP is a known repressor of Futsch expression (Zhang et al., 2001), and
interacts with the miRNA pathway (Jin et al., 2004). Because of this, and the fact that
miRNAs repress translation of a Futsch reporter in vitro (Figure 6C-F), we hypothesized
that FMRP might interact with miRs -9A, -9B, -9C, and -315 to repress Futsch translation.
To analyze this potential interaction, the first goal was to figure out if FMRP binds
directly to the Futsch mRNA, and if so, where that interaction occurs, using in vitro
analysis. Thus, an FMRP overexpression construct was designed and verified in its ability
to overexpress FMRP in S2 cells (Figures 12A-B) for co-expression with Futsch reporter
constructs. Primers were designed for PCR amplification of 12 different Futsch reporter
fragments (Figure 13D), and I trained an undergraduate in our lab, Nathan Boin, to clone
the fragments into the vector and perform dual-luciferase assays in S2 cells. He performed
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all of the assays seen in Figure 13B, with the exceptions of the UTRs. Leslie Rozeboom
cloned the 3’UTR, and I performed the dual-luciferase assay for this fragment. I cloned
the 5’UTR and performed the dual-luciferase assay. Ultimately, these results showed that
there was no significant decrease in Futsch reporter expression in any fragment of the
Futsch mRNA in response to FMRP overexpression compared to an empty vector control,
and there was even significant overexpression of the reporters in many cases (Figure
13C).
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Figure 13: FMRP Significantly Increases, Rather Than Decreases Expression of
Futsch Reporters In vitro
Boin (unpublished). (A) An FMRP overexpression vector was tested by transecting into
S2 cells and performing a Western Blot against FMRP using a protein extract from lysed
cells and comparing to extract from cells transfected with an empty expression vector (B)
FMRP overexpression was further validated by quantitative Western Blot analysis (C) S2
cells were transfected with a Renilla Luciferase control, an FLuc-Futsch fragment
reporter, and with either an empty vector (control), or an overexpression construct for
FMRP. Cells were lysed and Firefly Luciferase and Renilla Luciferase luminescence
were quantified. Raw Firefly Luciferase values were normalized to raw Renilla
Luciferase ratios, the mean value for the empty vector control was calculated, then the
ratios were normalized to this mean value to demonstrate % change. (D) For cloning
purposes, the entirety of the Futsch mRNA was divided into fragments, which were then
inserted into Firefly Luciferase reporter vectors for co-expression with FMRP and dualluciferase analysis. This is a linear image of the Futsch mRNA shown 5’ to 3’ measuring
the length in kilobases (red numbers at the bottom), above which are shown the extents
of each fragment (red boxes) labeled with their own corresponding letters and the basepair locations as measured from the 5’ end (black numbers inside red boxes). (E) Graphic
depicting the Futsch 3’UTR demarcated by the red arrow, with numerical base-pair
markers shown below. Included are labeled points for the predicted miR-9 family binding
site
(TargetScanFly.org)
and
a
predicted
G-quartet
(http://bioinformatics.ramapo.edu/GQRS). Error bars indicate mean ± SEM. Statistics:
One-way ANOVA with a Dunn’s post-test. *** p < 0.001.
Even if FMRP does not bind directly to the Futsch mRNA, it is still possible that
FMRP interacts with miRNAs to induce translational repression of target mRNAs.
Knowing that Futsch is a target of both FMRP (albeit indirectly), and four of the most
enriched miRNAs in the Drosophila CNS in an in vitro assay, it is plausible that if FMRP
interacts with any miRNAs to regulate its targets, miRs -9A, -9B, -9C and -315 are likely
candidates. Immunoprecipitation of FMRP was therefore performed on fly head extract
(Figure 14A), RNA was isolated, and qRT-PCR was performed using primer assays for
each of miRs -9A, -9B, -9C, -315, and U1 for a negative control. Extract from an FMRP
immunoprecipitation showed no enrichment of any of these five miRNAs over an IgG
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immunoprecipitation or immunoprecipitation with unconjugated magnetic beads. A
sample containing 10% of the input showed enrichment of all five miRNAs.
A

B

Figure 14: FMRP-Immunoprecipitated Extracts Are Not Enriched for miRs -9A, 9B, -9C or -315
(A) Cartoon depicting the use of an antibody-coated magnetic bead to coimmunoprecipitate FMRP with bound miRNAs. (B) FMRP was immunoprecipitated
from protein extracted from homogenized w1118 fly heads using Mouse anti-DFmr1
antibody (6A15) conjugated to magnetic beads. qRT-PCR analysis using SYBR Green
was performed on the eluant using primers for miRs -9A, -9B, -9C, -315, and negative
control U1. Results were compared to 10% protein extraction input, extract eluted from
immunoprecipitations using Mouse IgG antibody conjugated to magnetic beads, and
extract eluted from immunoprecipitations unconjugated magnetic beads.
Ultimately, the results show that FMRP does not significantly repress any portion
of the Futsch mRNA using in vitro reporters for each fragment, nor does it interact
physically with miRs -9A, -9B, -9C, or -315. However, miRNAs and FMRP are known
to interact with other translational repression pathways, including, particularly, P-bodies
(Pascual et al., 2012). Previous research has shown that FMRP not only co-localizes with
P-body components Me31B, Trailerhitch, and HPat, but also interacts genetically with
these P-body components (Barbee et al., 2006; Pradhan, unpublished). Knowing the
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importance of understanding translational repression mechanisms for the purposes of
synaptic structure modifications, the next step was to further examine the extent of the
relationships between DFmr1 P-body components.
Chapter 3.5: Analysis of Co-Localization of FMRP with P-Body Components
Though FMRP is known to co-localize and interact physically with some P-body
components, others have yet to be investigated. Thus, the first step was to analyze whether
FMRP co-localizes with Twin, and verify that it co-localizes with HPat (Pradhan,
unpublished) and Me31B (Barbee et al., 2006). Primary neuron cultures were prepared
using flies expressing YFP-FMRP, and stained with antibodies against Twin, HPat and
Me31B. Cultures were allowed to grow 3-5 days before fixing and immunostaining with
antibodies against P-body components, as well as a neuronal marker, Horse Radish
Peroxidase (HRP). Clear overlap was seen not only in the cell body, but also in substantial
amounts of the punctae in neurites (Figure 15). Quantification of co-localization in the
neurite punctae showed that Twin had the least co-localization with FMRP, with only
30.8% overlap with YFP fluorescence. Me31B showed substantially more overlap,
averaging 51.9%. The greatest co-localization was seen between FMRP and HPat, which
showed approximately 67.5% overlap between YFP-FMRP and endogenous HPat, and
62.3% overlap between GFP-HPat and endogenous FMRP (Table 10). Proximity of these
particles suggests the possibility of a physical interaction between FMRP and these Pbody components.
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Figure 15: Images of Co-Localization of FMRP and P-Body Components in
Primary Neuron Culture
Primary neuron cultures were prepared from the ventral ganglia of third-instar larvae
expressing the indicated fluorphore-tagged proteins. Cultures were allowed to grow for
3-5 days prior to fixing for 5 minutes, and staining with primary antibody followed by
secondary antibody conjugated to AlexaFluorophore-568 and Goat anti-HRP-Dylight649
(far red). Images were taken separately and overlaid using Adobe Photoshop. P-body
components tested by antibody are labeled on the left. Below each neuron image is an
expanded inset from the image depicted by the white box. Scale bars are equal to 5 µm.
Table 10: Percent Co-Localization of FMRP and P-Body Components
Genotype:
Antibody used
as a Reference:
Mouse  Me31B
Rabbit Twin
Rabbit  HPat
Mouse  DFmr1

# of punctae

# of neurons

210
127
295
114

4
4
10
3

YFP-FMRP

GFP-HPat

51.9
30.8
67.5
—

—
—
—
62.3

Images like those seen in Figure 15 were examined in Adobe Photoshop using separated
channels to initially circle punctae, then observing co-localization in circled punctae
using the channels overlay feature. A weighted average was calculated for each set of
neurons. Co-localization of fluorescence from P-body particles overlapping with FMRP
particles is expressed as a percent of total punctae.
To investigate whether FMRP physically interacts with P-body components, coimmunoprecipitation was used. An HA-tagged version of FMRP was designed and
permanently expressed it in an S2 cell line, into which V5-His-tagged P-body components
were then transfected: Twin, HPat, Me31B, and Dcp1, which I designed. I verified a
tagged version of FMRP was being expressed in S2 cells by isolating protein extract from
normal S2 cells, cells transfected with a normal FMRP overexpression plasmid, and cells
transfected with the HA-tagged FMRP, and performed a Western Blot using antibody
against FMRP. The control (untransfected) cells and cells transfected with normal FMRP
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show a single band between 75 kDa and 100 kDa. The cells transfected with HA-tagged
FMRP showed this same band, but also a higher band right at 100 kD (Figure A1). To
verify if this band was higher due to the HA tag, a blot with the same extracts was stained
with an antibody against HA. No bands were seen in the untransfected cells or cells
transfected with normal FMRP, but a single band matching in size at 100 kDa to the
higher band in the cells transfected with HA-tagged FMRP was seen (Figure A1).
To verify that tagged versions of Twin, Me31B, HPat, and Dcp1 were being
expressed in S2 cells, each P-body component was transfected into the cells, protein was
isolated, and Western Blot was performed for each using an antibody against V5. Without
a tag, endogenous Me31B typically appears at 50-55 kD (Igreja and Izaurralde, 2011;
Nakamura et al., 2001), Twin at around 63 kD (Temme et al., 2004), HPat at around 102
kD and 108 kD (Pradhan et al., 2012), and Dcp1 at around 43 kD (Braun et al., 2012).
The addition of the V5-His tag should increase each protein’s size by approximately 7
kD (Stothard, 2000). Bands appeared at the correct sizes on a Western Blot to suggest
tagged versions of Me31B, Twin, and Dcp1 were being successfully expressed, though
the tagged version of HPat did not show a band.
Protein extracts from each set of transfected cells were then added to
commercially-available magnetic beads coated with antibody against HA (Pierce) for
immunoprecipitation, then extracts were run on a protein gel and blotted for expression
of V5, and each respective protein, with the exception of Dcp1, for which we could not
obtain an antibody. 10% of the input from each immunoprecipitation reaction was also
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run on a gel in parallael for verification of initial expression of each protein in the S2
cells.
A

B

Figure 16: Co-Immunoprecipitation and Western Blot of HA-Tagged DFmr1 with
V5-His-Tagged P-Body Components
Cells with stable expression of HA-tagged FMRP were transfected with V5-His-tagged
versions of either Me31B, Twin, HPat, or Dcp1; negative controls were non-transfected
cells (bottom row labels). Protein extract (Input) was run on a protein gel and blotted for
(A) the V5 tag or endogenous proteins (left column labels), then (B)
immunoprecipitations (IP) against HA were performed on each extract, and the eluants
were run on a gel and blotted for the V5 tag or endogenous proteins (left column labels).
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The input control Western Blot shows expression of tagged FMRP (indicated by
the double bands) in all extracts. The V5 tag appears in all extracts except for the control
cells, which were not transfected with a V5-tagged P-body component, and cells
transfected with V5-tagged HPat. When probed using antibodies against endogenous
proteins, all extracts show expression of Me31B, Twin, and HPat (antibody was not
available for Dcp1). In the extract transfected with V5-tagged Me31B, two bands appear
at different sizes in the range of 50-60 kD, one matching the endogenous bands found in
other extracts, the other a bit higher. Antibody against Twin shows two bands very close
to each other in all extracts in the range of 60-70 kD, with the possible shadow of a third,
higher band in the extract transfected with V5-tagged Twin, and curiously, also in the
extract transfected with V5-tagged Dcp1. Interestingly, in the extract transfected with V5tagged Dcp1, HPat expression was not as strong, as the band appeared faint in comparison
to the band seen from other cell extracts, and slightly higher on the gel.
Blots of HA-FMRP immunoprecipitated extracts from each set of transfected cells
show a strong band indicating successful immunoprecipitation of the HA-tagged FMRP
using anti-DFmr1 antibody. The V5 tag co-precipitated with HA-FMRP in Me31B-V5transfected cells, Dcp1-V5-transfected cells, and, although it is very difficult to see in this
image, a very faint band appeared suggesting minimal co-precipitation with Twin-V5 in
transfected cells. The V5 tag did not appear to co-precipitate with HA-FMRP in cells that
were not transfected with any tagged proteins, or with HPat-V5 in HPat-V5-transfected
cells. Antibody against endogenous Me31B shows co-precipitation of Me31B with
FMRP in all extracts, though interestingly, two bands are not seen in the extract from
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Me31B-V5-transfected cells. Also, endogenous HPat appears to have co-precipitated
with HA-FMRP in extracts transfected with HPat-V5, where a very strong band is seen,
with Dcp1-V5-transfected extracts and Twin-V5-transfected extracts, where a fainter, but
visible band is also seen, and finally, in control cells, though the band appears slightly
lower than in the HPat-V5-transfected cells or the Dcp1-V5-transfected cells. Curiously,
there was no band suggesting co-precipitation of HPat with FMRP in cells transfected
with V5-Me31B. Twin did not appear to co-precipitate with FMRP in any of the extracts.
Ultimately, these results suggest that FMRP co-immunoprecipitates strongly with
Me31B and Dcp1. It also co-immunoprecipitates with endogenous HPat, though
strangely not in extracts overexpressing V5-tagged Me31B. FMRP also does not coimmunoprecipitate with V5-tagged HPat, or with endogenous Twin, though it may
weakly co-immunoprecipitate with the tagged version of Twin.
Chapter 3.6: Analyzing the Effects of Genetic Interactions Between FMRP and PBody Components at the Drosophila NMJ
As stated previously, FMRP has been shown to interact with P-body components
not only physically, but also genetically. After examining the interactions between FMRP
and P-body components by physical proximity and physical association in an
immunoprecipitated complex, the next step was to see if these genetic interactions
between FMRP and P-body components can, in fact, affect the structure of the Drosophila
NMJ.
The first step in examining the genetic role of DFmr1 and P-body components at
the NMJ was to repeat previous unpublished experiments by Sarala Pradhan to validate
her results suggesting a genetic interaction between FMRP and HPat to influence NMJ
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structure. NMJ analysis at muscles 6/7 and muscle 4 showed that larvae that were
heterozygous for two different deletions of FMRP (DFmr1Δ50 and DFmr1Δ113), or
heterozygous for a single deletion of HPat (HPatΔ3), showed no significant change in 1B
bouton numbers compared to a CantonS/w1118 (Iso31) control. This was also true for total
bouton count, except in the case of the DFmr1Δ113 heterozygote, which showed a
significant increase in total bouton numbers (Figure 17C). In contrast, transheterozygotes DFmr1Δ113/HPatΔ3 and DFmr1Δ50/DFmr1Δ113 showed a significant
increase in 1B bouton numbers at muscles 6/7 (Figure 17A) and also in total bouton
numbers at muscles 6/7 and at muscle 4 over wildtype controls (Figure 17C-D).
Homozygotes for HPatΔ3 showed an increase in 1B boutons only (Figure 17A). Larvae
that were trans-heterozygous DFmr1Δ50/HPatΔ3 showed a significant increase in 1B
bouton numbers only at muscle 4 (Figures 17A and 17D), and the only significant shift
in number of 1S boutons at muscles 6/7 or terminal tips at muscle 4 observed, were with
a trans-heterozygous deletion of DFmr1 (Figure 17B).
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Figure 17: FMRP Interacts Genetically with P-Body Component HPat to Affect
Synaptic Growth
Virgin w1118(Iso31) flies were crossed to the Δ113 allele and the Δ50 allele for DFmr1,
and the Δ3 allele for HPat. Virgin flies containing the Δ113 allele or Δ50 allele for DFmr1
were crossed to male flies containing the Δ3 allele for HPat, and each of the DFmr1
alleles were also crossed to each other. Third-instar larval offspring were screened for
absence of a larval marker, then dissected, fixed, and stained with Mouse anti-Discs Large
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antibody followed by Goat anti-Mouse AlexaFluor-488 and Goat anti-HRP-Dylight649
(far red). (A-C) Muscles 6/7 and (D-E) muscle 4 from segment A3 were imaged on a
confocal microscope, then the number of (A) 1B, (B)1S, and (C) total boutons were
quantified from muscles 6/7. (D) Total boutons and (E) terminal tips were quantified for
muscle 4. Error bars indicate mean ± SEM. Statistics: One-way ANOVA followed by
Tukey’s post-test. **p < 0.01, *** p < 0.001 and **** p < 0.0001.
Analysis of NMJ modifications in response to FMRP knock-down or HPat knockdown not only served to investigate the potential interaction between these two proteins,
but also to indicate which FMRP deletion line was most effective for FMRP-induced
increase in bouton numbers. The average number of boutons was greater for the
DFmr1Δ113 line than the DFmr1Δ50 line for all muscles and boutons examined, suggesting
it is the superior line for NMJ analysis for this purpose. Thus, to investigate the interaction
between FMRP and other P-body components, I next performed crosses for deletions of
each of these components and DFmr1Δ113.
When compared to a CantonS/w1118(Iso31) control, only the DFmr1Δ113/HPatΔ3,
Dfmr1Δ113/Twin12209, and DFmr1Δ50/Dfmr1Δ113 trans-heterozygotes showed a significant
increase in the number of 1B boutons and total boutons over wildtype controls (Figures
17A and 17C). When compared to the Dfmr1Δ113 heterozygote, only the
DFmr1Δ113/HPatΔ3 and DFmr1Δ113/Dfmr1Δ50 trans-heterozygote showed a significant
increase in 1B bouton numbers, and none of the genotypes showed significant increases
in total bouton numbers over the DFmr1Δ113 heterozygote. Heterozygotes and transheterozygotes for Me31B and Dcp1 showed no significant changes in 1B bouton or total
bouton numbers compared to the CantonS/w1118(Iso31) control or the DFmr1Δ113
heterozygote (Figures 17A and 17C). Interestingly, only the Dcp1442P heterozygote and
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DFmr1Δ50/Dfmr1Δ113 trans-heterozygote showed a significant increase in 1S bouton
numbers over the CantonS/w1118(Iso31) controls (Figure 18B).
A

B

C

Figure 18: Genetic Effects of the Loss of P-Body Components and FMRP at the
Drosophila NMJ
Virgin flies from the w1118(Iso31) line, as well as virgin flies from the DFmr1Δ113 lines
were crossed to males containing the HPatΔ3 allele, the Twin12209 allele, and Dcp1442P
allele. Third-instar larval offspring were screened for absence of a larval marker, then
dissected, fixed, and stained with Mouse anti-Discs Large antibody followed by Goat
anti-Mouse AlexaFluor-488 and Goat anti-HRP-Dylight649 (far red). (A-C) Muscles 6/7
from segment A3 were imaged on a confocal microscope, then the number of (A) 1B,
(B)1S, and (C) total boutons were quantified from muscles 6/7. Error bars indicate mean
± SEM. Statistics: One-way ANOVA followed by Tukey’s post-test. **p < 0.01, *** p
< 0.001 and **** p < 0.0001.
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Given that the larvae homozygous for HPatΔ3 showed a statistically significant
increase in bouton numbers compared to controls, this suggests that P-body components
may play a role in influencing NMJ structure independently of FMRP. Therefore, the next
experiment was to test this possibility. New deletion lines for Twin, Me31B, and Dcp1
were crossed to a w1118(Iso31) control and to the deletion lines previously tested, and it
was found that both Twin8115 and Dcp1442P heterozygous expression produced a
significant increase in 1B boutons at muscles 6/7, which was increased in Twin by the
trans-heterozygous expression of Twin12209, but not in Dcp1 with additional expression of
the Dcp1b53 allele. Homozygous expression of HPatΔ3 also produced a significant
increase in 1B boutons over controls, but heterozygous expression did not (Figure 18A).
The increase in bouton numbers resulting from Twin8115 was seen only in 1B boutons, not
1S (Figure 18B), though the increase in 1B boutons was significant enough from transheterozygous expression of both Twin knock-down alleles that it still caused a significant
increase in total boutons over controls (Figure 18C). HPatΔ3 expression did not produce
a significant increase in 1S boutons or overall bouton numbers. Heterozygous expression
of the Dcp1442P allele did lead to an increase in 1S boutons (Figure 18B), which also led
to a significant increase in total boutons over controls (Figure 18C). However, this did
not culminate in a more significant increase in bouton numbers when Dcp1442P was transheterozygously expressed with Dcp1b53.
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Figure 19: The Genetic Effects of P-Body Component Knock-Down on Bouton
Numbers at the Drosophila Neuromuscular Junction
Virgin female w1118(Iso31) flies were crossed to males of each of CantonS wildtype flies,
or flies containing each of the following alleles: HPatΔ3, Me31BΔ2, Me31BΔ1, Twin12209,
Twin8115, Dcp1442P and Dcp1b53, and flies for either allele for each P-body component
were crossed to each other. Larvae were selected using a larval balancer marker for each
gene, then dissected, fixed, and stained with Mouse anti-Discs Large antibody followed
by Goat anti-Mouse AlexaFluor-488 and Goat anti-HRP-Dylight649 (far red). (A-C)
Muscles 6/7 and (D-E) muscle 4 from segment A3 were imaged on a confocal
microscope, then the number of (A) 1B, (B)1S, and (C) total boutons were quantified
from muscles 6/7. Error bars indicate mean ± SEM. Statistics: One-way ANOVA
followed by Tukey’s post-test. **p < 0.01, *** p < 0.001 and **** p < 0.0001.
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Chapter Four: Analysis and Discussion
Chapter 4.1: Analysis of Differential Expression of miRNAs
Processes of learning and long-term memory are largely dependent upon new
protein synthesis and fine-tuned expression at the synapse in response to activity
stimulation (Saab et al., 2014). As translational repressors, miRNAs underlie processes
of protein expression from pathways ranging from neurogenesis (Follert et al., 2014) to
cancer regulation (Li et al., 2014), and therefore hold the potential to regulate protein
expression associated with learning and long-term memory. miRNAs have shown
involvement in the fine-tuning expression of proteins underlying synaptic plasticity
(Sosanya et al., 2013) and dendritic spine formation (Schratt et al., 2006). However, each
miRNA is capable of repressing many targets (Lewis et al., 2005; Friedman et al., 2009;
Li et al., 2014), and each potential target mRNA may be regulated by multiple miRNAs
(Bartel, 2009), so there is still much to be discovered regarding which miRNAs regulate
expression of which proteins involved in synaptic growth and modifications. Part of
unveiling precisely which miRNAs may be involved neuronal development is first to
establish which miRNAs are expressed in neurons in the first place, and second, how that
expression changes in different stages of development. For the purposes development and
growth in Drosophila, including the growth of neurons and overall development of the
neuromuscular junction, the most important

81

transition may be the transition from the larva to the adult. Therefore, we utilized NextGeneration Sequencing (NGS) and analysis for comparison of absolute expression of
miRNAs from the larval Central Nervous System (CNS) to the adult brain.
Initially, the number of reads generated from this dataset was approximately 94
million reads. Trimming of adapter sequences, filtering for quality and size decreased
these numbers to little over 1 million reads per extract. Though this process substantially
decreased the number of reads, it helped to ensure the reliability of our data by ensuring
analysis of only the highest quality reads, and 1 million reads is still a large dataset for
the purposes of miRNA analysis. The reads were then processed using the MPI-HLR
miRNA pipeline (MIRPIPE; Kuene et al., in press). MIRPIPE clusters NGS reads
together that differ only at the 3’ end, which can be classified as isomers of miRNAs
“isomiRs,” which can result from Dicer and Drosha processing errors (Morin et al., 2008;
Martí et al., 2010). Other databases and processing techniques do not necessarily take
isomiRs into account, and therefore can underestimate the number of reads for a particular
miRNA when those reads do not match database records one hundred percent (Lee et al.,
2010). However, studies show that these isoforms are still valid, as they typically deviate
by only 1-2 nucleotides at the 3’ end, which is far less stringent in its requirements for
precise base-pair matching to targets (Guduric-Fuchs et al., 2012); therefore, these
isomiRs still target the same mRNAs and thus were counted in the total number of reads
in each tissue.
One of the best-known molecular models for synaptic growth associated with
learning and long-term memory in Drosophila is analysis of the neuromuscular junction
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(NMJ) after trains of synaptic stimulation (Shen and Ganetzky, 2010). Because of this,
our greatest interest was examining the expression of miRNAs in the larval CNS.
Comparison of absolute expression of miRNAs in terms of reads-per-million between the
larval CNS and adult brain showed the strongest enrichment for miRs-315, -184, -276A,
-92B, and -10 (Figure 3) in the larval CNS compared to the adult brain. This list of
miRNAs is interesting in and of itself because of the difference in overall expression.
However, as this study’s focus is on the roles of miRNAs to regulate neuronal growth, it
seemed that the even more interesting miRNAs would be those that were not only most
enriched in the larval CNS, but also those with the greatest number of potential targets
pertaining to neuronal development.
To analyze the significance of these miRNAs relative to potential targets, we
utilized the fact that miRNAs typically require 100% complementarity to their targets in
a 7-8 base-pair seed region—base-pairs 2-8 or 2-9 of the miRNA (Lucas and Raikhel,
2013), and the online program TargetScanFly, which compares the seed region sequences
of known miRNAs to potential target mRNAs. TargetScanFly compares miRNA seed
regions to potential matches in mRNAs, and examines conservation of these sites between
Drosophila species. The idea behind this process is that if a miRNA binding to a target
mRNA is important for development, those sequences will be conserved throughout
many species. Thus, an increase in the conservation of a miRNA-mRNA binding site
increases the likelihood of a relevant interaction (Ruby et al., 2007).
To further analyze the potential role of these miRNAs, the compiled lists of
mRNA targets for each miRNA were processed using the Database for Annotation,
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Visualization and Integrated Discovery (DAVID). DAVID compiles lists of functional
annotations for each given gene, then groups these functional annotations together into
groups where the functions are similar or seemingly related. It also gives the value for the
enrichment of the given genes by a modified Fisher Exact P-Value (Huang et al., 2009A;
Huang et al., 2009B). Ultimately, this analysis revealed that the miR-9 family and miR315 are strongly predicted to regulate mRNAs involved in neuronal development and
differentiation; both the miR-9 family and miR-315 also are predicted to regulate
overlapping targets, which in turn, are strongly enriched in the functions for cytoskeleton
rearrangement, which is key for neuronal growth (Prokop et al., 2013), and neuronal
development (Table 8). Overlapping targets for miR-315 and miR-275 showed
enrichment for a similar functional annotation group (Table 9). Altogether, these results
strongly support the notion that these miRNAs are of key interest to us for better
understanding the processes underlying learning and long-term memory. However, it is
important to note that while these functional annotation groups were formed between
miRs -315 and the miR-9 family and miR-275, the other 2 most abundant miRNAs/
miRNA families, the miR-92 family and miR-11, formed more unpredictable groups.
Interestingly, the most-enriched functional annotation clusters for miR-11 with
enrichment scores of 7.04 and 5.04 from the DAVID program predicted miR-11 to bind
mostly to targets involved in cellular membranes or DNA transcription (Table A9 and
data not shown). These include members of immunoglobulin families and transmembrane
signaling proteins. Members of the immunoglobulin superfamily include cell adhesion
molecules (Ig-CAMs), which are essential for synaptic plasticity (Lüthl et al., 1994;
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Muller et al., 2000), LTP (Staubli et al., 1998), and Long-Term Depression (LTD; Bukalo
et al., 2004), by regulating the activities of NMDA receptors and calcium ion channels
(Dityatev et al., 2008). The role of cell adhesion molecules in synaptic growth is wellunderstood, as interactions between these molecules can trigger signaling cascades to
induce new synaptic formation or structural modifications of existing synapses (Dalva et
al., 2007; Wainwright and Galea, 2013). Similarly, transmembrane signaling proteins,
such as Frizzled, a predicted target of miR-11, are highly involved in synaptic growth.
These signaling pathways trigger neuron outgrowth, cell proliferation and differentiation,
and thus affect synaptic growth (Shah et al., 2009; Zhong, 2008).
The miR-92 family, which was by far, the most fold-enriched of the abundanceenriched miRNAs in the larval CNS, was most predicted to regulate targets associated
with transcription regulation and DNA binding (Table A1). As mentioned previously, this
was also the second-most enriched functional annotation target cluster for miR-11. While
immediate modifications to the synapse such as those involved in early Long-Term
Potentiation (LTP) require immediate increase in protein synthesis from pools of
translationally inhibited mRNAs, further modifications associated with long-term
memory, such as late LTP, require an increase in protein transcription (Costa-Mattioli et
al., 2009). Current models of long-term memory formation stipulate that, prior to synaptic
stimulation, mRNAs necessary for neuronal growth and synaptic modification are
transcribed in the neuronal cell body and held in a state of repression by RNA transport
granules, which include translational repressor proteins, as well as miRNAs. These
granules move into the dendrites and maintain the mRNAs in a state of repression until
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they are needed—upon synaptic stimulation—at which point, the granules dissociate,
allowing for rapid translation and synthesis of proteins essential for synaptic growth
(Sánchez-Carbente and Desgroseillers, 2008). Thus, it is conceivable that while some
miRNAs such as miRs -315, -275, and the miR-9 family are associated with such granules
involved in temporary repression of mRNAs related to neuronal development, others,
such as the miR-92 family, and potentially miR-11, are more involved with the
transcriptional activation necessary for late LTP.
Overall, the significant enrichment of miRs -315, -275, -11, the miR-9 family, and
the miR-92 family in the larval CNS compared the adult brain, and the fact that most of
these miRNAs are predicted to regulate targets with known involvement in neuronal
growth, differentiation, and synaptic plasticity strongly implicates these miRNAs in
neuronal development. The only deviant from this pattern is the miR-92 family, which,
incidentally, also showed the strongest fold-enrichment in the larval CNS compared to
the adult brain. While the other enriched miRNAs seem to show heavy and direct
involvement with regulating members of neuronal growth pathways, the miR-92 family
is most strongly predicted to regulate targets involved in transcription. It is possible, given
the evidence that transcription is also an essential component of learning and long-term
memory, that the miR-92 family is contributing to synaptic modifications underlying
these processes in this way.
Overall, the miRNAs of greatest interest for investigating processes of learning
and long-term memory, based on their abundance and fold-enrichment, as well as their
predicted ability to regulate targets associated with these processes, are miRs -315, -275,

86

-11, and the miR-9 family. By temporarily repressing translation of mRNAs key to
synaptic growth, these small molecules potentially provide the mechanism for specific
expression to induce growth at synapses in response to synaptic stimulation, serving as
the basis for strengthened synaptic connections thought to underlie learning and longterm memory formation. It is important to recognize that while the seed region sequence
is essential for miRNA binding to mRNA targets, it is by no means the only determining
factor for this association. To identify mRNAs with a greater likelihood of being true
targets, it is important to consider other factors using other target prediction algorithms
(Tarang and Weston, 2014). This would be a good idea for future studies trying to find
the relevant targets of these miRNAs, as targets that appear using multiple algorithms are
more likely to be true targets. This evaluation would also help to narrow down the list of
possible targets. However, the only true way to determine if a mRNA is a specific target
of a miRNA, is to test this interaction directly. Thus, the next step in our process of
understanding learning and long-term memory is to figure out what these miRNAs are
targeting.
Chapter 4.2: Larvally-enriched miRNAs Target Futsch in vitro but Not Necessarily
in vivo
Based on our results, the miR-9 family and miR-315 clearly show repression of a
Futsch 3’UTR reporter in vitro (Figure 6) when overexpressed, and this interaction is
sequence-specific to the miRNA binding sites. Each of miRs -9A, -9B, -9C, and -315
strongly repressed Firefly Luciferase to Renilla Luciferase ratios more than two-fold
compared to an empty vector control, and this effect was obliterated by mutagenesis of
the seed-region binding sequences for the miR-9 family and miR-315, as previously
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shown by Leslie Rozeboom (unpublished). However, this interaction is not necessarily
seen in vivo (Figure 9 and 10). Even with the observance of phenotypes from multiple
lines expressing the sequences used to overexpress miRNAs in S2 cells, there was no
apparent decrease in bouton number or bouton size that would be indicative of a decrease
in Futsch expression (Figure 10; Roos et al., 2000). In fact, the only significant
phenotypes observed in response to overexpression of the miR-9 family or miR-315 using
a pan-neuronal or motor neuron driver was an increase in the number of boutons—the
opposite of what would be expected if Futsch levels were decreased. Thus, it is possible
that although these miRNAs target and repress a Futsch reporter in vitro, they may not
target Futsch in vivo. However, there are other possible explanations for the absence of a
Futsch-deficient phenotype.
One possible explanation for the absence of a phenotype indicative of decreased
Futsch expression is that the miRNA overexpression constructs are not functional. It is
important to note that while we have tested the efficacy of these miRNAs in vitro using
a target reporter, we have not yet verified that these constructs overexpress the miRNAs
in vivo. Our lab is working on a Venus reporter under the control of the tubulin promoter
for insertion into fly lines. Once this reporter is generated, we could insert the target
sequence for these miRNAs into the 3’UTR of the reporter, then cross the flies expressing
the reporter to flies overexpressing the miRNA under a Patched Gal-4 driver to express
these constructs in wing discs, and examine for decreased reporter expression to verify
that the miRNA constructs function properly in vivo as well.
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Another potential explanation for the absence of an effect for miRNA
overexpression is the fact that these miRNAs are already so abundant in the larval CNS
(Figure 3), that increasing expression might produce little tangible effect. An
overabundance of miRNAs would saturate the potential targets, preventing additional
miRNAs from binding to them. Additionally, every miRNA has numerous potential
targets (Chi et al., 2009; Helwak et al., 2013; Iyengar et al., 2014), therefore, it is possible
that the miRNAs being overexpressed in each of these fly lines is affecting multiple
targets, some of which may normally repress synaptic growth. If a repressor of synaptic
growth were a greater target for the miR-9 family and miR-315, overexpression of these
miRNAs would lead to a decrease in synaptic growth. Therefore, while the
overexpression of the miR-9 family and miR-315 did not produce the phenotype expected
of Futsch repression, these results are by no means surprising.
Chapter 4.3: Knock-Down of the miR-9 Family and miR-315 in vitro Does Not Show
De-Repression of a Futsch Reporter
Futsch reporter expression does not increase when miRNA sponges are
transfected into S2 cells (Figure 8) nor do larvae express increased bouton numbers or
decreased bouton size when these sponges are expressed in fly lines using the UAS-Gal4
system (Figure 12). Dual-luciferase assays including the Futsch 3’UTR reporter and miR9 or miR-315 sponges produced ambiguous results, suggesting that down-regulation of
these miRNAs does not lead to up-regulation of this reporter in vitro. We know that the
sponges function, because insertion of each sponge into its own Firefly Luciferase
reporter and transfection with miRNA overexpression plasmids led to strong repression
of this reporter in S2 cells. However, miR-9B was unable to bind to the miR-9 sponge
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sequence in order to repress the reporter (Figure 7). The reason for this may be due to a
single nucleotide shift in the miR-9B sequence compared to the miR-9A and miR-9C
sequences, which could affect the ability of the miRNA to bind to the target. This shift in
nucleotides and the inability of miR-9B to bind to the miR-9 sponge could explain why
there is no up-regulation of a Futsch 3’UTR reporter in vitro. Even if the sponges
transfected into S2 cells are able to knock down miR-9A and miR-9C expression,
endogenous miR-9B still exists and is capable of repressing the Futsch 3’UTR reporter
on its own (Figure 6), therefore, transfection of the miR-9 sponge would not necessarily
induce an increase in Futsch 3’UTR reporter expression. Contrastingly, miR-315 is not
at all abundant in S2 cells (Chung et al., 2008), therefore, introduction of an
overexpression vector into the cells would indeed lead to the repression of the Futsch
3’UTR reporter, but introduction of a miR-315 sponge might have no effect because there
are so few endogenous miRNAs to repress the reporter in the first place, preventing any
visible de-repression from occurring.
Chapter 4.4: Knock-Down of the miR-9 Family in vivo Shows Increased Synaptic
Growth Characteristic of an Increase in Futsch Expression, But
Knock-Down of miR-315 Does Not Produce the Same Effect
Our experiments suggest that miR-9B is somewhat abundant in the Drosophila
larval CNS, though the expression is the least of any of the miR-9 family, and its
abundance is little over 1,000 reads per million (0.1%). Ergo, expression of a miR-9
sponge that affects only miR-9A and miR-9C might be ineffective at de-repressing
Futsch. However, a significant phenotype was observed at the NMJ when two copies of
a miR-9 sponge were expressed in a single fly, suggesting that miR-9A and miR-9C may
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in fact be important in repressing a target—or multiple targets—essential for synaptic
growth. Whether or not that target is Futsch is a question to be examined with future
studies. A simple way to examine this would be to use the same larvae examined in
Figures 10 and 11, isolate protein and RNA from the CNS from these larvae, and perform
a quantitative Western Blot and qRT-PCR on these two separate extracts to analyze for
Futsch abundance compared to a control in response to expression of the miR-9
overexpression plasmid or the miR-9 sponge.
miR-9 in mammals matches the Drosophila miR-9A sequence completely
(Aravin et al., 2003), and is highly enriched in the mammalian brain (Lagos-Quintana et
al., 2002; Sempere et al., 2004). In mammalian embryonic stem cells, inhibition of miR9 results in decreased neuronal differentiation (Krichevsky et al., 2006). In Drosophila,
miR-9A affects sensory neuron and organ development, but does not absolutely switch
expression of its targets off by its expression. Ergo, while the expression of miR-9A may
be essential for neuronal development, it is not the sole determining factor of whether or
not synaptic growth is repressed (Li et al., 2006). Numerous models have proposed that
miRNAs, while obviously relevant for study, may act more as a buffering system for
translational regulation rather than sole managers of mRNA fate. The effects seen in these
studies potentially support this idea, though the significant changes in the number of
boutons resulting from miR-9 knock-down suggest otherwise.
One potential caveat to the absence of a synaptic phenotype in response to miR315 knock-down is that miR-315 is so much more abundant than any other miRNA in the
larval CNS (Figure 3), that it may be impossible to knock down this miRNA sufficiently
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to see a phenotype. Its abundance and the fact that it is predicted to regulate groups of
targets responsible for synaptic growth (Figure 3 and Table 7) suggests that it is playing
a very important role in synaptic development; therefore, it would be worth investigating
the role of miR-315 further. One way to knock down miRNA expression in vivo more
efficiently would be to generate a miR-315 deletion line. Currently, no commerciallyavailable deletion fly lines exist for miR-315 according to FlyBase.org, though one was
generated and published using the Clustered Interspersed Short Palindromic Repeat
(CRISPR) technique (Kondo and Ueda, 2013). Using commercially-available plasmids
and the plasmid used in that experiment, it may be possible to generate a stable miR-315
deletion fly line using the CRISPR technique. I have generated primer sequences for this
purpose and borrowed the plasmid used in Kondo and Ueda (2013) for generating miR315 deletion fly line, and in the near future, our lab can generate this line for analysis of
miR-315’s effects on NMJ structure. Further, if deletion of one copy of miR-315 is
insufficient and a homozygous deletion is not viable, it would also be possible to cross a
miR-315 deletion fly to any of the miR-315 sponge lines I have generated to knock down
miR-315 expression further without completely eliminating it to see if such a decrease in
expression would have an effect.
Chapter 4.5: FMRP Does Not Interact Directly with the Futsch mRNA or miRs 9A, -9B, -9C and -315
Although we have not yet verified repression of Futsch in vivo by the miR-9
family or miR-315, the in vitro results are compelling. Further, there is strong evidence
suggesting that FMRP not only binds to the Futsch mRNA and represses Futsch
expression (Zhang et al., 2001), but also interacts directly with miRNAs (Edbauer et al.,
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2010) and components of the miRNA pathway (Jin et al., 2004). Thus, we were interested
in finding out if FMRP and miRs -9A, -9B, -9C, and -315 interact to physically bind and
repress Futsch translation.
The first step in this process was to figure out if and where FMRP may bind to
Futsch to repress expression. For this, we used an in vitro approach. An FMRP
overexpression was generated from a cDNA clone available from DGRC (see Materials
and Methods) and verified its role as an overexpression plasmid by Western Blot (Figure
13). Generation of a Futsch reporter was more involved. The Futsch mRNA is extremely
large, encompassing close to 20 kilobases in length (Flybase.org; St. Pierre et al., 2014),
and forming a product over 500 kilodaltons (Hummel et al., 2000), which is too large for
insertion into a single vector for examination by in vitro analysis. Hence, I broke up the
Futsch mRNA into 12 manageable fragments (in addition to the 3’UTR reporter already
generated by Leslie Rozeboom) for insertion into a Firefly Luciferase reporter for
expression in S2 cells (Figure 13D).
Results demonstrated that not only did FMRP not significantly repress any of the
Futsch reporter fragments, but also significantly increased the FLuc/RLuc ratio for many
fragments. There is one important caveat to the analysis performed here, and that is the
fact that each of these Futsch reporters was inserted into a vector originally designed to
test 3’UTRs. Therefore, the reporters occur within the 3’UTR region of Firefly
Luciferase, and do not contain a 3’UTR or polyadenylation sequence of their own.
Absence of a polyA signal can affect mRNA translation and stability (Ford et al., 1997;
Preiss and Hentze, 1998). Therefore, to be sure these unexpected results are not artifacts
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of improper mRNA processing, these experiments could be repeated by adding an SV40
3’UTR with a polyadenylation signal like that included in the RLuc control vector.
However, in the absence of a proper polyadenylation signal, previous research suggests
that translation should be hindered, not enhanced (Zhao et al., 1999). Furthermore, there
is recent evidence that the polyadenylation signal may not be essential for RNA
translation (Searfoss and Wickner, 2012), indicating that the enhanced FLuc/RLuc ratio
is most likely due to FMRP overexpression alone, rather than some combination with
improper translation of the Firefly Luciferase reporter. This suggests a potential role for
FMRP as a translational activator, rather than a translational repressor, which has been
seen in previous research (Bechara et al., 2009; Soden and Chen, 2010; Gross et al.,
2011), even pertaining to MAP1B expression (Chen et al., 2003). The possibility of
FMRP acting as a translational activator would contradict the study by Zhang et al. (2001)
off of which this study was based, but it could be investigated by examining Futsch
abundance in FMRP-deficient flies using Western Blot of head extract, or quantification
of a unique loop structure formed by Futsch at the NMJ (Roos et al., 2000).
Another possible explanation for the up-regulation, rather than down-regulation
of Futsch reporters by FMRP is that FMRP has previously been shown to bind and repress
expression of Renilla Luciferase (Chen et al., 2014). If FMRP selectively represses
Renilla Luciferase, then overexpression of FMRP in S2 cells with a dual-luciferase assay
could lead to a significant increase in the FLuc/RLuc ratio by decreasing RLuc
expression. Additionally, if the artificially-introduced RLuc reporter is a better target for
FMRP in this in vitro assay than the Futsch reporters we are testing, then we will not be
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able to see the Futsch reporter repression. This possibly explains why none of the assays
including a Futsch reporter show a decrease in the FLuc/RLuc ratio compared to controls
in which FMRP was not overexpressed. Further, this proposition is supported by the fact
that when increased amounts of FMRP were added to S2 cells with one of the Futsch
reporters, we saw a dose-dependent increase in the FLuc/RLuc ratio (Figure A2). Future
studies should examine whether or not RLuc expression is being affected by cotransfection with an FMRP overexpression plasmid by performing quantitative Western
Blot analysis on transfected S2 cells. Antibodies against Firefly Luciferase and Renilla
Luciferase are commercially available for this purpose (www.pierce-antibodies.com). If,
in fact, RLuc expression is being manipulated by FMRP, it might be more prudent to cotrasfect the FLuc reporter and FMRP overexpression plasmid, and instead of performing
a dual-luciferase assay, simply perform quantitative Western Blot analysis to see if the
reporter is being down-regulated.
Although we were not able to show direct binding of FMRP to Futsch reporters
in an in vitro assay, the evidence suggesting that FMRP translationally represses Futsch
in vivo is compelling (Zhang et al., 2001). Plus there is the possibility that despite being
and RNA-binding protein, FMRP’s interaction with Futsch is more indirect. Regardless
of whether FMRP is interacting directly with the Futsch mRNA or some other target, the
fact remains that FMRP has a known role as a repressor of translation (Laggerbauer et
al., 2001; Li et al., 2001; Muddashetty et al., 2007) and that this is a potential mechanism
for FMRP’s inhibition of synaptic growth (Todd et al., 2003; Vanderkilsh and Edelman,
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2005). Understanding not only which targets FMRP represses, but also how it represses
targets is therefore essential.
FMRP interacts with components of the miRNA pathway in Drosophila and
mammals (Caudy et al., 2002; Xu et al., 2004; Ishizuka et al., 2002; Lugli et al., 2005;
Kelley et al. 2012; Xu et al., 2012; Tian et al., 2013), and immunoprecipitates with mature
miRNAs that, when mis-expressed, affect synaptic growth (Edbauer et al., 2010). It has
therefore been proposed that miRNAs may mediate FMRP translational repression for
the purposes of affecting synaptic structure, which could provide an indirect link between
FMRP and translational repression of the target Futsch. The overall enrichment of the
miR-9 family and miR-315 in larval CNS and their demonstrated ability to repress a target
known to affect synaptic growth in vitro therefore makes them excellent candidates as
potential interactors with FMRP.
To examine a potential interaction between FMRP and the miRNAs of interest in
a physical complex, an immunoprecipitation against FMRP was performed in fly head
extract, the RNA was isolated from the eluant, and qRT-PCR analysis of these miRNAs
was performed and compared to negative control immunoprecipitations (IgG and beadsonly), and compared to a U1 negative control (small RNA that is not predicted to interact
with FMRP). Figure 14 shows clearly that there is no enrichment of miRs -9A, -9B, -9C
or

-315

in

an

FMRP

immunoprecipitation

extract

compared

to

an

IgG

immunoprecipitation extract or immunoprecipitation extract from magnetic beads only.
All of the small RNAs did appear at a lower cycle number—suggesting greater
abundance—in the input control, which contained 10% of the extract that was used for
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the immunoprecipitation, demonstrating that these small RNAs were present in the initial
extract.
Ultimately, the role of the miR-9 family and miR-315 are yet to be elucidated.
The analysis provided thus far on Futsch suggests that it may be a target of repression by
these miRNAs and thus they may affect synaptic growth. However, more detailed
analysis using better knock-down techniques is needed to discern if these miRNAs do in
fact, repress targets responsible for synaptic growth, and if Futsch is specifically the target
underlying this modification. Furthermore, although FMRP is known to interact with both
Futsch and miRNAs, it does not appear to interact with the miR-9 family or miR-315 to
co-regulate Futsch translation. It is still possible that FMRP interacts with other miRNAs
to repress other targets, but further analysis should be performed to investigate these
potential interactions.
Chapter 4.6: FMRP Co-Localizes and Interacts in a Physical Complex with Some
P-Body Components
The final translational repression pathway we wanted to investigate as a potential
effector of synaptic structure was P-bodies. FMRP has known interactions with P-body
components (Barbee et al., 2006; Wang et al., 2008). It also acts as a repressor of synaptic
growth (Zalfa et al., 2003; Lu et al., 2004; Nahm et al., 2010). Therefore, we sought to
investigate whether FMRP requires P-body components for this function.
In yeast, the homolog for Twin (CCR4) initiates 3’ trimming of mRNAs
designated for 5’ to 3’ degradation, and associates with both Pat1/Mrt1p (HPat homolog)
and Dcp1/Dcp2 (Meyer et al., 2004; Tharun and Parker, 2001). It has thus been proposed
that mRNAs targeted for 5’ to 3’ degradation are selectively deadenylated by Twin, which
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is followed by association with Pat1/Mrt1p (HPat homolog) and Dcp1/Dcp2 for the
purposes of decapping and 5’ to 3’ degradation. The mammalian homolog of Twin
(CCR4) interacts with the homolog for Me31B (Rck) in vivo, and these two proteins are
mutually dependent upon each other for expression in P-bodies (Andrei et al., 2005). Such
tight associations as those required by interacting P-body components suggests that, at
the very least, these proteins should be found in close proximity to each other in cells.
FMRP has been shown interact with P-body components by co-localization, but
this co-localization is never one hundred percent. P-bodies are known to be very
heterogeneous RNPs, and FMRP is known to associate with other granule types beyond
P-bodies (Wang et al., 2008; Barbee et al., 2006). It is therefore not surprising that even
with such strong interactions as those shown with HPat and Me31B, there is not complete
overlap of these P-body components and FMRP (Figure 15). In fact, the percent colocalization between FMRP and Me31B is similar to previous published studies, albeit
slightly lower (Barbee et al., 2006), and percent co-localization of FMRP with HPat
nearly matches previous findings from our lab (Pradhan, unpublished). Surprisingly, the
co-localization of FMRP with Twin was much lower than with that of either Me31B or
HPat, though it was still significant, as the two proteins co-localized in nearly 31% of all
observed punctae in cultured neurons. This again demonstrates the overall heterogeneity
not only of P-bodies, but also of FMRP’s association with RNP complexes. The overlap
suggests that FMRP is associating with these P-bodies for a purpose, which is most likely
translational regulation. This theory, however, would be better supported by
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demonstration of actual interactions between FMRP and P-body components in physical
complexes.
FMRP has previously shown to co-immunoprecipitate with Me31B (Barbee et al.,
2006) and HPat (Pradhan, unpublished) in Drosophila, indicating that the proposed
physical interaction with P-bodies does in fact, occur. However, to validate these prior
findings and further elucidate FMRP’s interaction with P-bodies, we coimmunoprecipitated FMRP with the P-body components Me31B, Twin, HPat, and Dcp1.
Expression of tagged constructs in S2 cells was validated by Western Blot showing both
the HA tag for FMRP, and the V5 tag for Me31B, Twin, and Dcp1, and by endogenous
antibodies for all proteins examined except Dcp1 (Figure 16A).
Immunoprecipitation of FMRP was verified by Western Blot using anti-DFmr1
antibody. Tagged and endogenous Me31B co-immunoprecipitated with FMRP, as did
tagged Dcp1, and endogenous HPat. There was a very faint association of tagged Twin
with FMRP, but this was not mimicked with endogenous Twin, suggesting that the minor
interaction may have been more of a byproduct of the V5-His tag rather than a real
association of FMRP and Twin in a physical complex (Figure 16B). However, this should
be further investigated, possibly by expressing more of the tagged Twin construct in S2
cells to enhance the interaction. An untagged construct could also be used to overexpress
endogenous Twin in an attempt to view if there is any interaction between FMRP and the
endogenous protein.
The fact that HPat was not seen intact with the V5 tag in the original extract
indicates that the tag may have had an effect on the protein itself and prevented proper
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folding and/or expression of HPat from the transgenic construct. However, the fact that
endogenous HPat still co-immunoprecipitated with the tagged FMRP indicates that the
two proteins do in fact, interact in a physical complex, even in the absence of
overexpression or a tag. Interestingly, this interaction between tagged FMRP and
endogenous HPat did not occur in the control (untransfected) extract, or the extract from
cells transfected with tagged Me31B. However, it is important to note that these two
extracts were on the other side of the original blot from the other three extracts that did
show and interaction between FMRP and endogenous HPat, and the band in those three
extracts was not incredibly strong, which suggests the absence of a band in the control
lane and Me31B extract lane may be due to simple experimental variation. To verify the
HPat results, this experiment should be repeated. And further enhancement of the
interaction between HPat and FMRP could occur, similar to enhancing any potential
interaction with Twin, by generating a construct for overexpression of native HPat and
transfecting it into S2 cells prior to immunoprecipitation.
In any case, the fact that FMRP co-localizes with Me31B, Twin, and HPat, and
previous studies have shown also, Dcp1 (Eystathioy et al., 2003), shows that FMRP
physically interacts with these proteins and they exist together in a complex. P-bodies are
known sites of translational repression and mRNA degradation (Sheth and Parker, 2003;
Anderson et al., 2009; Walters et al., 2014), therefore, in a model where translational
repression is key to control of synaptic growth, P-bodies are an essential component.
Given FMRP’s known role as a repressor of synaptic growth, and the fact that and this
interaction with P-body components occurs in neurons, this suggests that the mechanism
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by which FMRP represses synaptic growth may be translational repression mediated by
P-bodies.
Chapter 4.7: FMRP Interacts Genetically with P-Body Component HPat to Affect
NMJ Structure
A previous graduate student in our lab, Sarala Pradhan, performed NMJ analyses
suggesting that the P-body component HPat is essential for FMRP repression of synaptic
growth. I verified her results, demonstrating that a simultaneous deletion of one copy of
DFmr1 and HPat significantly enhances the number of boutons at the NMJ at muscles
6/7 and at muscle 4 over both wildtype controls and flies with the deletion of only a single
copy of either gene (Figure 17). This increase in bouton numbers is modest, but
significant as well as consistent, suggesting that HPat does in fact, affect FMRP’s ability
to repress synaptic growth at the NMJ. However, it must be noted that this increase in
bouton numbers was not nearly as significant as the increase generated by knocking down
two copies of FMRP. This indicates that while HPat does potentially mediate the role of
FMRP as an inhibitor of synaptic growth, there are clearly other factors at work that could
play a more major role in affecting synaptic structure.
Chapter 4.8: FMRP Does Potentially Interact with Other P-body Component Twin,
But Not Me31B or Dcp1 to Affect NMJ Structure
To investigate whether any of the other potential factors affecting FMRP function
at the NMJ could be additional P-body components, I performed additional fly crosses
with deletion lines of Me31B, Twin, and Dcp1. We learned from the experiment
demonstrating an FMRP interaction with HPat that the DFmr1Δ113 allele is stronger in its
effects on NMJ structure than the DFmr1Δ50 allele. In all cases where either DFmr1Δ50 or
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DFmr1Δ113 were used, crosses including DFmr1Δ113 always showed more boutons at the
NMJ than those including DFmr1Δ50 (Figure 17). I therefore used the DFmr1Δ113 allele
for all crosses where knock-down of FMRP was investigated. These crosses showed no
statistically significant change in the number of boutons at muscles 6/7 when a single
copy of a DFmr1 deletion was expressed with a single copy of a deletion for Me31B,
Twin, or Dcp1, compared to a fly with a single copy of DFmr1 deleted, suggesting that
none of these factors assist FMRP in synaptic structure modification. However, the
DFmr1Δ113; Twin12209 trans-heterozygotes did show a significant increase in the number
of boutons compared to wildtype controls, suggesting that Twin could potentially mediate
FMRP modification of NMJ structure, but if so, its effect is even more modest than that
of HPat, and not much more significant than the effect of the DFmr1Δ113 allele by itself.
Chapter 4.9: P-body Component Twin May Affect NMJ Structure By Itself, But
Dcp1 and Me31B Do Not
When investigating the interaction between HPat and FMRP at the NMJ, we
found that deletion of 2 copies of HPat was sufficient to induce a statistically significant
increase in bouton number compared to wildtype controls independent of FMRP. This
was also previously published (Pradhan et al., 2012). Thus, P-body components are
capable of affecting synaptic structure on their own. I next investigated the possible roles
of other P-body components: Me31B, Twin, and Dcp1, in affecting synaptic structure at
the NMJ by performing additional fly crosses with heterozygous expression of deletions
of each of these components that I had not already investigated, and trans-heterozygous
deletions using two different deletion lines for each component.
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Heterozygous deletion of Twin using the Twin8115 allele led to a significant
increase in 1B boutons, but this was further enhanced by double-deletion of Twin.
However, this increase in 1B boutons only led to a significant increase in total boutons
with the Twin8115 allele expressed heterozygously, not when co-expressed with the
Twin12209 allele. This is likely due to the fact that there was a noticeable but not
statistically significant decrease in the number of 1S boutons resulting from the doubledeletion of Twin. Interestingly, this effect was not seen at all with either allele when
expressed heterozygously; it was a cumulative effect from combining both deletion lines.
Ultimately, Twin may have an effect on synaptic growth that increases the number of 1B
boutons at the expense of 1S boutons.
Double-deletion of Me31B, or Dcp1 produced no statistically significant increase
in the number of boutons at muscles 6/7 like that seen with a double-deletion of HPat.
The Dcp1442P allele did lead to a very significant increase in both 1B boutons and 1S
boutons, and therefore, total boutons when expressed heterozygously, but not when coexpressed with another Dcp1 deletion allele Dcp1b53. Dcp1442P is a null allele for Dcp1,
while Dcp1b53 still expresses residual fragments of the protein. It may be possible that
Dcp1b53 is somehow compensating for Dcp1442P, but this is highly unlikely given previous
published results indicating that Dcp1b53 also acts as a Dcp1 deletion line (Chen et al.,
2006). Thus, the increase in bouton count resulting from Dcp1442P is more likely due to
some other effect beyond the absence of Dcp1. Given that Dcp1442P results an imprecise
excision, it is possible that other genes were excised with Dcp1, which in turn, could have
unforeseen effects on synaptic growth. This suggests that although these components
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Me31B and Dcp1 exist in the same P-body complexes, they do not necessarily perform
the same functions to inhibit synaptic structural growth. Thus, among the P-body
components examined, HPat and Twin appear to have a genetic effect on synaptic
structure, while Me31B and Dcp1 do not.
Chapter 4.10: Concluding Remarks
Altogether, the research presented here elucidates the role of translational
regulation mechanisms in affecting synaptic structure by examination of the interactions
between different components of ribonucleoproteins. Analysis of differential expression
of miRNAs in the Drosophila CNS at different developmental stages implicates miRs 315, miR-275, miR-11, and the miR-9 family as strong potential regulators of neuronal
growth and development. The substantial enrichment of these miRNAs in the Drosophila
larval CNS compared to the adult brain and enrichment of potential targets with
functional annotations pertaining to neuronal growth strongly suggests these miRNAs
should be examined to determine what their targets are, and the effects of those targeted
interactions.
In these studies, we investigated the roles of miRs -315 and the miR-9 family as
potential regulators of Futsch. We validated the specific targeting of a Futsch reporter by
these miRNAs in vitro, and further investigation could potentially show this effect in vivo.
The small changes in structure that occurred at the NMJ in response to miRNA
overexpression, and larger structural modifications that occurred in response to miRNA
under-expression suggest that knocking down miRNA expression is a superior method
for examining their effects at the NMJ.
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Although we could not demonstrate an interaction between neuronally-enriched
miRNAs and FMRP to co-regulate Futsch, the fact remains that FMRP interacts with the
miRNA pathway potentially to mediate repression of synaptic growth. Our results suggest
that this repression is somewhat mediated by P-body components, particularly HPat and
potentially Twin. We verified that FMRP does co-immunoprecipitate with Me31B and
HPat, both of which were shown in previous unpublished studies. However, the physical
association of FMRP with Dcp1 is a novel interaction, as is co-localization with Twin.
Together, these results suggest a mechanism by which FMRP interacts with P-bodies for
translational repression resulting in repression of synaptic growth. The interaction is weak
in all cases, suggesting it may not be the most important mechanism in this process, or
that stronger mediators of this process may exist. As stated previously, all of the P-body
components investigated in this study are involved in the 5’ to 3’ mRNA degradation
pathway, whereas the miRNA pathway can lead to either translational repression or
degradation. FMRP associates in heterogeneous complexes; it is possible that part of the
time it associates with P-bodies as part of a mRNA degradation pathway, and at other
times, associates with miRNAs for translational repression.
Clearly, there is still a significant amount of investigation necessary to elucidate
the processes of translational repression as they relate to neuronal growth. However, the
research presented here demonstrates the importance of enriched miRNAs in the
Drosophila CNS, their potential role in affecting neuronal growth independently and
interacting with FMRP, the interactions between FMRP and multiple P-body
components, and the role of individual P-body components in affecting neuronal growth.

105

Together, these translational mechanisms can result in significant structural changes at
the neuromuscular junction, indicative of the potential for functional effects,
as well.
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Appendix: Additional Tables and Figures
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Figure A 1: Larval Enrichment of all miRNAs found in Larval CNS and Adult Brain

Table A 1: Functional Annotation Cluster for Predicted the miR-92 Family Targets
Enrichment Score: 6.95
Cluster Name
Sequence-specific DNA binding
Transcription factor activity
DNA-binding
Regulation of transcription, DNA-dependent
Transcription regulator activity
Regulation of RNA metabolic process
Regulation of transcription
DNA binding
DNA binding
RNA polymerase II transcription factor activity
Homeobox
Transcription
Transcription regulation
Homeobox
Homeodomain-related
Transcription
Homeobox, conserved site
Nucleus
HOX
DNA-binding region:Homeobox
Enrichment Score: 3.51
Cell morphogenesis
Cellular component morphogenesis
Cell projection organization
Neuron differentiation
Dendrite morphogenesis
Dendrite development
Neuron development
Cell projection morphogenesis
Cell part morphogenesis
Cell morphogenesis involved in differentiation
Neuron projection morphogenesis
Neuron projection development
Cell morphogenesis involved in neuron
differentiation
Axonogenesis
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P-Value
7.40E-13
1.20E-11
1.60E-10
2.10E-08
2.10E-08
3.50E-08
4.70E-08
4.90E-08
1.20E-07
1.60E-07
2.20E-07
2.70E-07
2.80E-07
6.80E-07
1.10E-06
1.30E-06
2.30E-06
1.60E-05
3.50E-05
4.80E-03
1.20E-07
3.80E-07
4.40E-06
3.00E-05
4.20E-04
4.20E-04
1.30E-03
1.40E-03
2.00E-03
2.10E-03
3.00E-03
3.10E-03
3.20E-03
3.20E-01

Table A 2: Functional Annotation Cluster for Predicted miR-275 Targets
Enrichment Score: 2.38
Cluster Name
Immunoglobulin
Immunoglobulin-like fold
Immunoglobulin-like
Immunoglobulin subtype 2
Immunoglobulin subtype
IGc2
IG
Immunoglobulin V-set
Immunoglobulin I-set
Fibronectin, type III
FN3
Enrichment Score: 1.74
Cell morphogenesis
Cellular component morphogenesis
Neuron projection morphogenesis
Neuron projection development
Cell morphogenesis involved in neuron
differentiation
Cell morphogenesis involved in
differentiation
Cell projection morphogenesis
Cell part morphogenesis
Neuron development
Cell projection organization
Neuron differentiation
Dendrite morphogenesis
Dendrite development
Axonogenesis
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P-Value
1.50E-04
5.90E-04
9.20E-04
3.70E-03
4.00E-03
7.40E-03
8.10E-03
1.00E-02
1.50E-02
1.90E-02
3.10E-02
2.10E-03
4.60E-03
1.10E-02
1.20E-02
1.20E-02
1.40E-02
1.70E-02
1.90E-02
2.20E-02
2.60E-02
3.70E-02
5.20E-02
5.20E-02
1.30E-01

Table A 3: Functional Annotation Cluster for Predicted Targets of miR-282
Enrichment Score: 1.48
Cluster Name
Imaginal disc-derived wing vein specification
Epidermal growth factor receptor signaling
pathway
Imaginal disc morphogenesis
Post-embryonic organ morphogenesis
Post-embryonic organ development
Compositionally biased region:Gln-rich
Instar larval or pupal morphogenesis
Post-embryonic morphogenesis
Metamorphosis
Cell surface receptor linked signal transduction
Imaginal disc development
Imaginal disc-derived wing morphogenesis
Wing disc morphogenesis
Instar larval or pupal development
Post-embryonic appendage morphogenesis
Post-embryonic development
Imaginal disc-derived appendage morphogenesis
Appendage morphogenesis
Imaginal disc-derived appendage development
Appendage development
Wing disc development
Transmembrane receptor protein tyrosine kinase
signaling pathway
Enzyme linked receptor protein signaling
pathway
Developmental protein
Pattern specification process
Cell fate commitment
Alternative splicing
Splice variant
Regionalization
Nucleus
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P-Value
2.30E-03
2.90E-03
3.30E-03
3.30E-03
3.90E-03
4.40E-03
6.70E-03
7.20E-03
7.80E-03
1.10E-02
1.20E-02
1.20E-02
1.30E-02
1.30E-02
1.40E-02
1.50E-02
1.60E-02
1.60E-02
1.60E-02
1.70E-02
2.40E-02
2.50E-02
4.20E-02
8.40E-02
9.10E-02
9.60E-02
1.10E-01
1.50E-01
2.80E-01
5.10E-01

Table A 4: Functional Annotation Cluster for Predicted Targets of miR-184
Enrichment Score: 3.06
Cluster Name
Septate junction assembly
Apical junction assembly
Cell-cell junction assembly
Cell junction assembly
Cell-cell junction organization
Cell junction organization
Endothelial cell development
Epithelial cell development
Endothelial cell differentiation
Septate junction
Regulation of tube size, open tracheal system
Regulation of tube size
Epithelial cell differentiation
Occluding junction
Regulation of tube architecture, open tracheal
system
Apical junction complex
Apicolateral plasma membrane
Respiratory system development
Open tracheal system development
Cell-cell junction
Plasma membrane part
Epithelium development
Cell junction
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P-Value
7.70E-06
3.30E-05
4.10E-05
4.50E-05
7.30E-05
7.90E-05
4.20E-04
4.20E-04
4.20E-04
9.80E-04
1.00E-03
1.30E-03
1.50E-03
1.50E-03
3.60E-03
3.80E-03
4.50E-03
5.40E-03
5.40E-03
6.90E-03
1.00E-02
1.70E-02
3.60E-02

Table A 5: Functional Annotation Cluster for Predicted Targets of the miR-276
Family
Enrichment Score: 2.4
Cluster Name
Positive regulation of adenylate cyclase activity
Positive regulation of cyclase activity
Positive regulation of lyase activity
Regulation of adenylate cyclase activity
Regulation of cAMP metabolic process
Regulation of nucleotide biosynthetic process
Regulation of cyclic nucleotide biosynthetic process
Regulation of cyclic nucleotide metabolic process
Regulation of cyclase activity
Regulation of cAMP biosynthetic process
Regulation of lyase activity
Regulation of nucleotide metabolic process
cAMP-mediated signaling
Cyclic-nucleotide-mediated signaling
Positive regulation of catalytic activity
Positive regulation of molecular function
Second-messenger-mediated signaling
Intracellular signaling cascade

P-Value
1.80E-03
1.80E-03
2.10E-03
2.60E-03
2.60E-03
2.60E-03
2.60E-03
2.60E-03
2.60E-03
2.60E-03
3.00E-03
3.50E-03
4.60E-03
5.20E-03
7.90E-03
1.10E-02
1.80E-02
4.10E-02

Table A 6: Functional Annotation Cluster for Predicted Targets of miR-10
Enrichment Score: 1.28
Cluster Name
Sequence-specific DNA binding
Transcription factor activity
Regulation of transcription, DNA-dependent
Regulation of RNA metabolic process
Regulation of transcription
Transcription regulator activity
DNA binding
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P-Value
1.20E-02
3.20E-02
5.10E-02
6.10E-02
8.20E-02
8.80E-02
1.20E-01

Table A 7: Functional Annotation Cluster for Predicted Targets of miR-305
Enrichment Score: 6.19
Cluster Name
Transcription regulator activity
Transcription factor activity
Transcription
Regulation of transcription
Transcription regulation
Transcription
Regulation of transcription, DNA-dependent
Regulation of RNA metabolic process
RNA polymerase II transcription factor
activity
Nucleus
DNA binding
Regulation of transcription from RNA
polymerase II promoter
DNA binding
Enrichment Score: 3.26
Neuroblast differentiation
Neuroblast fate commitment
Cell fate commitment
Cell fate determination
Neuroblast fate determination
Ventral cord development

P-Value
2.00E-10
7.60E-09
2.80E-08
3.30E-08
6.10E-07
8.00E-07
3.80E-06
3.90E-06
4.20E-06
6.00E-06
7.60E-06
3.00E-05
6.40E-05
1.60E‐05
1.80E‐04
2.30E‐04
1.10E‐03
1.40E‐03
2.40E‐02

Table A 8: Functional Annotation Cluster for Predicted Targets of miR-995
Enrichment Score: 1.67
Cluster Name
Imaginal disc development
Neuron differentiation
Tube morphogenesis
Tube development
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P-Value
1.80E-03
3.20E-02
5.30E-02
7.00E-02

Table A 9: Functional Annotation Cluster for Predicted Targets of miR-11
Enrichment Score: 7.04
Cluster Name
Integral to membrane
Intrinsic to membrane
Transmembrane
Membrane
Enrichment Score: 3.47
cell morphogenesis
cell part morphogenesis
neuron differentiation
cellular component morphogenesis
neuron projection morphogenesis
neuron projection development
cell morphogenesis involved in neuron
differentiation
cell morphogenesis involved in differentiation
cell projection morphogenesis
cell projection organization
neuron development
cell motion
dendrite morphogenesis
dendrite development
axonogenesis
axon guidance

P-Value
9.60E-11
2.00E-10
9.70E-06
3.80E-04
2.70E‐05
5.80E‐05
5.90E‐05
6.00E‐05
7.30E‐05
7.60E‐05
8.00E‐05
1.60E‐04
3.10E‐04
6.20E‐04
8.50E‐04
1.30E‐03
2.70E‐05
5.80E‐05
5.90E‐05
6.00E‐05

Tables A1‐A9: Predicted miRNA targets from TargetScanFly were analyzed with the DAVID
bioinformatics program functional annotation cluster analysis tool. The top functional
annotation cluster is shown for each miRNA, and any functional annotation cluster pertaining
to neuronal growth with an enrichment score over 1.5 is shown at the bottom of each table.
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Table A 10: Functional Annotation Cluster for Overlapping Predicted Targets of miR315 and the miR-92 Family
Enrichment Score: 2.29
Cluster Name
DNA-binding
Zinc-finger
Transcription regulation
Transcription
Steroid hormone receptor
Nuclear hormone receptor, ligand-binding
Nuclear hormone receptor, ligand-binding,
core
Steroid hormone receptor activity
Zinc finger, nuclear hormone receptor-type
zinc finger region:NR C4-type
DNA-binding region:Nuclear receptor
ligand-dependent nuclear receptor activity
Zinc finger, NHR/GATA-type
HOLI
Transcription
ZnF_C4
Receptor
Transcription factor activity
Regulation of RNA metabolic process
Regulation of transcription, DNA-dependent
Sequence-specific DNA binding
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P-Value
3.40E-04
4.80E-04
1.40E-03
1.50E-03
1.80E-03
2.10E-03
2.10E-03
3.10E-03
3.50E-03
4.00E-03
4.50E-03
4.50E-03
4.80E-03
6.50E-03
6.60E-03
1.10E-02
2.50E-02
2.70E-02
3.80E-02
7.70E-02
8.00E-02

Table A 11: Functional Annotation Cluster for Overlapping Predicted Targets of the
miR-9 Family and the miR-92 Family
Enrichment Score: 1.48
Cluster Name
Zinc finger
Cell fate determination
Zinc ion binding
Cell fate commitment
Zinc finger, C2H2-type/integrase,
DNA-binding
Compound eye development
Eye development
Transition metal ion binding
RNA polymerase II transcription
factor activity
Neuron differentiation
Sensory organ development
Zinc
Transcription
Zinc finger, C2H2-type
Zinc finger, C2H2-like
Metal ion binding
Cation binding
Ion binding
Zinc-finger
Metal-binding
Transcription regulation
Transcription
DNA-binding
Regulation of transcription
ZnF_C2H2
Transcription regulator activity
DNA binding
Phosphoprotein
Nucleus
Zinc finger
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P-Value
1.50E-03
2.50E-03
7.10E-03
8.00E-03
8.40E-03
1.40E-02
1.60E-02
1.90E-02
2.00E-02
2.40E-02
2.40E-02
2.70E-02
3.00E-02
3.70E-02
3.80E-02
4.40E-02
4.80E-02
4.90E-02
5.00E-02
6.00E-02
7.20E-02
7.40E-02
8.20E-02
8.20E-02
9.60E-02
1.20E-01
1.60E-01
2.40E-01
2.70E-01
1.50E-03

Table A 12: List of Overlapping Targets for miR-315 and the miR-9 Family
FlyBase Gene ID
FBgn0001122
FBgn0003870
FBgn0004579
FBgn0005638
FBgn0015609
FBgn0020307
FBgn0020412

Gene
G protein alpha 47A
Tramtrack
spalt major
slow border cells
Cadherin-N
defective proventriculus
Chromosomal serine/threonineprotein kinase JIL-1
Dmel_CG5004
Dmel_CG9098
Liprin-gamma
Dmel_CG13589
specifically Rac1-associated
protein 1
Dmel_CG33473
SCAR
Ataxin-binding protein 1
Dmel_CG32333
Dmel_CG6006
Dmel_CG34126
Dmel_CG34371
Futsch

FBgn0030820
FBgn0031762
FBgn0034720
FBgn0035011
FBgn0038320
FBgn0040765
FBgn0041781
FBgn0052062
FBgn0052333
FBgn0063649
FBgn0083962
FBgn0085400
FBgn0085416
FBgn0037585
FBgn0001122
FBgn0003870
FBgn0004579
FBgn0005638
FBgn0015609
FBgn0020307
FBgn0020412

G protein oalpha 47A
Tramtrack
spalt major
slow border cells
Cadherin-N
Defective proventriculus
Chromosomal serine/threonineprotein kinase JIL-1
Dmel_CG5004
Dmel_CG9098

FBgn0030820
FBgn0031762
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Table A 13: List of Overlapping Targets for miR-315 and miR-275
FlyBase Gene ID
FBgn0086758
FBgn0044028
FBgn0005631
FBgn0033368
FBgn0004055
FBgn0033551

Gene
Uzipped
Roundabout
Notum
CG13743
Chinmo
CG7222

Table A 14: List of Overlapping Targets for miR-315 and the miR-276 Family
FlyBase Gene ID
Gene
FBgn0052206
CG32206
FBgn0036725
CG18265
FBgn0051140
CG31140
FBgn0052062
Ataxin-binding protein 2
FBgn0000633
Faint sausage
FBgn0003715
Jim lovell
FBgn0036464
Synaptotagmin-beta
FBgn0033368
CG13743
FBgn0052830
Abrupt
FBgn0037976
Tachykinin
FBgn0015269
Neurofibromin 1
FBgn0050177
CG30177
Tables A10-A14: Predicted targets for each miRNA were determined using
TargetScanFly, then combined in an Excel spreadsheet to look for overlap of potential
targets. Overlapping target lists were compiled and processed using the DAVID
bioinformatics program and the tool for functional annotation cluster analysis. The most
enriched functional annotation cluster is shown for each set of overlapping miRNA
potential targets. Targets with known roles in neuron development are shown in bold.
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Table A 15: Potential miR-315 Targets Involved in Neuron Development
FlyBase Gene ID
FBgn0015589
FBgn0020510
FBgn0015609
FBgn0086758
FBgn0024277
FBgn0036274
FBgn0041781
FBgn0022764
FBgn0000546
FBgn0028734
FBgn0001085
FBgn0004435
FBgn0001325
FBgn0000464
FBgn0015773
FBgn0015774
FBgn0020912
FBgn0040294
FBgn0003380
FBgn0085450
FBgn0013433
FBgn0023097
FBgn0023095
FBgn0016794
FBgn0024245
FBgn0000578
FBgn0011592
FBgn0016797
FBgn0020294
FBgn0035106
FBgn0005631
FBgn0016061
FBgn0038320
FBgn0003870
FBgn0004055

Gene
APC-like
Abelson Interacting Protein
Cadherin-N
Chronologically inappropriate
morphogenesis
Dmel_CG18214
Dmel_CG4328
Dmel_CG4636
Dmel_CG8815
Ecdysone receptor
Fragile X mental retardation syndromerelated protein 1
Frizzled
G protein alpha49B
Kruppel
Leukocyte-antigen-related-like
Netrin-A
Netrin-B
Pituitary homeobox 1 homolog
Plenty of SH3s
Shaker
Sno oncogene
beaten path Ia
bonus
capricious
daughter of sevenless
doughnut on 2
enabled
frazzled
frizzled 2
knockout
rhinoceros
roundabout
sidestep
specifically Rac1-associated protein 1
tramtrack
unzipped
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Table A15: Predicted targets of miR-315 from TargetScan were compiled and analyzed
with the functional annotation cluster analysis tool from the DAVID bioinformatics
program. This table shows the list of potential miR-315 targets involved in neuron
development.

Figure A 2: An HA-tagged Version of FMRP Can Be Expressed in S2 Cells
Protein was isolated from untransfected S2 cells (control), S2 cells transfected with an
endogenous FMRP overexpression vector (FMRP), and S2 cells transfected with a
3xHA-3x-FLAG-tagged version of FMRP (Tagged FMRP). A Western Blot was
performed against each extract using (A) Mouse-anti-DFmr1 (6A15) antibody or (B)
Rat anti-HA.
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Figure A 3: Dose-Dependent Increased Expression of a Futsch Fragment G
Reporter in Response to FMRP Overexpression
A dual-luciferase assay was performed using a Firefly-Luciferase reporter for Futsch
Fragment G (Figure 13) in S2 cells and increasing amounts of FMRP (indicated below
the x-axis) with a Renilla Luciferase transfection control. FLuc/RLuc ratios increased
significantly with increasing amounts of FMRP transfected into S2 cells compared to
cells transfected with an empty vector in place of FMRP.
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Fly Lines/Groups of Fly Lines Generated:
UAS: mCherry-miR-9sp(15x) (Line 1) / CyO ; TbSb/DI
Kr/CyO; UAS: mCherry-miR-9sp(15x) (Line 2) / TbSb
Kr/CyO; UAS: mCherry-miR-9sp(15x) (Line 5) / DI
UAS: FH-FMRP
Kr/CyO; UAS: mCherry-miR-315sp(20x) (Line 1) / TbSb
Kr/CyO; UAS: mCherry-miR-315sp(20x) (Line 2) / TbSb
UAS: mCherry-miR-315sp(20x) (Line 6)/ CyO ; TbSb/DI
UAS: mCherry-miR-958 (Line 1) on II
Kr / CyO; UAS: mCherry-miR-958 (Line 3) / TbSb
Kr / CyO; UAS: mCherry-miR-958 (Line 5) TbSb
UAS: mCherry-miR-8
UAS: mCherry-miR-289
UAS: mCherry-miR-315
UAS: mCherry-miR-1
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